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Abbreviations 
2D Two-dimensional 
ACN Acetonitrile 
Agr Accessory gene regulation 
AHL N-acyl homoserine lactone 
AI-2 Autoinducer-2 
AIP Autoinducer peptide 
ATCC American Type Culture Collection 
BA Bovine serum 
BSA Bovine serum albumin  
CFU Colony forming unit 
DMSO Dimethyl sulfoxide 
DSMZ Deutsche sammlung von Mikroorganismen und Zellkulturen GmbH 
DTT Dithiothreitol 
ESI-MS Electrospray ionization mass spectrometry 
EtOH Ethanol 
FT-ICR-MS Fourier transform ion cyclotron resonance mass spectrometry 
g Gram 
GC-EI-MS Gas chromatography electrospray ionization mass spectrometry 
GC-MS Gas chromatography mass spectrometry  
h Hour 
HAI-1 N-(3-hydroxybutyryl)-homoserine lactone 
HCl Hydrogen chloride 
HPLC High performance liquid chromatography 
HSL Homoserine lactone 
HSQC Heteronuclear single quantum Coherence 
K2HPO4 Potassium hydrogen phosphate 
KCl potassium chloride 
LB Lysogenic broth 
M Molar (mol/l) 
m Milli 
m/z Mass-to-charge ratio 
MB Marine broth 
MeOH Methanol 
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MHz Mega Hertz 
min Minute 
ml Milliliter 
MLST Multilocus sequence typing 
MS Mass spectrometry 
NaCl Sodium chloride 
nm Nanometer 
NMR Nuclear magnetic resonance 
OD Optical density 
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QS Quorum sensing 
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rRNA Ribosomal RNA 
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Sar Staphylococcus accessory regulation 
SDS Sodium dodecyl sulphate 
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Trp Tryptophan 
TSB Tryptic Soy Broth 
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UV Ultraviolet 
WT Wild type 
WTA Wall teichoic acid 
yayurea A N-[2-(1H-indol-3-yl)ethyl]-urea 
yayurea B N-(2-phenethyl)-urea 
  
  Symbols 
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Summary 
This thesis addressed bacterial communication between Gram positive and Gram 
negative bacteria. The knowledge that many pathogens rely on cell-to-cell 
communication mechanisms known as quorum sensing, opens a new disease 
control strategy: quorum quenching. While studying the interaction of staphylococci 
with Gram-negative bacteria, we came across another communication system in a 
Staphylococcus intermedius group (SIG) species which can act as a zoonotic 
pathogen. This is one of the rare examples where Gram-positive bacteria excrete 
two compounds in comparatively high amounts that suppress the quorum sensing 
signaling and inhibit the growth of a broad spectrum of Gram-negative beta- and 
gamma-proteobacteria. The excreted compounds, named yayurea A and B, were 
isolated from S. delphini and structurally characterized. In vitro studies with the N-
acyl homoserine lactone (AHL) responding receptor LuxN of V. harveyi indicated that 
both compounds stimulated the LuxN-mediated phosphorylation of LuxU and caused 
the opposite effects with AHL. Furthermore, growth of yayurea A and B producing S. 
delphini is not suppressed by respiratory toxins when co-cultured with P. aeruginosa. 
Taken together, yayureas are presumably involved in self-protection and ensuring 
competitiveness in natural environments shared with Gram-negatives. In the second 
part of thesis, the role of protein A in Staphylococcus aureus adhesion to ethylene 
glycol coated surfaces was investigated. It was found that the coating materials, HS-
(CH2)11EG3OMe (EG3OMe) and poly-ethylene-glycol (PEG) prevented bacterial 
adhesion of S. aureus cells. However, pretreatment of EG3OMe and PEG coatings 
with -globulins or serum strongly promoted adherence of S. aureus cell. 
Furthermore, the spa-deletion mutant S. aureus, lacking the IgG binding protein A, 
showed reduced adherence and pretreatment of S. aureus with serum significantly 
decreased adherence. These results suggested that -globulins play a crucial role in 
promoting S. aureus cells adhesion by its IgG binding proteins. Particularly γ-
globulins bound to the coated surfaces thus mediating adherence of S. aureus via its 
protein A. Intercepting this adherence should prove to be useful in preventing biofilm 
formation.  
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Zusammenfassung 
Diese Arbeit behandelt bakterielle Kommunikation zwischen Gram-positiven und 
Gram-negativen Bakterien. Mit dem Wissen, dass viele Krankheitserreger auf Zell-
zu-Zell-Kommunikation setzen (Quorum Sensing), öffnet sich eine neue Strategie 
der Krankheitsbekämpfung: Quorum quenching. Während Interaktionsstudien von 
Staphylokokken mit Gram-negativen Bakterien sind wir auf ein neuartiges 
Kommunikationssystem gestoßen in dem zwei Substanzen in vergleichsweise hohen 
Mengen von Bakterien der Staphylococcus intermedius Gruppe ausgeschieden 
werden, welche Quorum Sensing-Signale und das Wachstum eines breiten 
Spektrums von Gram-negativen beta-und gamma-Proteobakterien unterdrücken. Die 
ausgeschiedenen Verbindungen, yayurea A und B, wurden von S. delphini isoliert 
und strukturell charakterisiert. In vitro-Studien mit dem N-Acylhomoserinlacton 
(AHL)-Rezeptor LuxN von V. harveyi zeigten, dass beide Verbindungen die LuxN-
vermittelte Phosphorylierung von LuxU stimulieren und den entgegengesetzten 
Effekt zu AHL verursachen. Darüber hinaus wird das Wachstum des Yayurea A und 
B produzierenden S. delphini nicht durch die von P. aeruginosa produzierten 
Atemgifte während der Kokultivierung gehemmt. Zusammengefasst ist zu vermuten, 
dass Yayureas beim Selbstschutz und der Sicherung der Wettbewerbsfähigkeit der 
Produzenten in der natürlichen Umgebung mit Gram-negativen Bakterien beteiligt 
sind. Im zweiten Teil der Arbeit wurde die Rolle von Protein A bei der Adhäsion von 
S. aureus an Ethylenglykol beschichteten Oberflächen untersucht. Wir konnten 
zeigen, dass die Stoffe HS-(CH2) 11EG3Ome (EG3OMe) und Polyethylenglykol 
(PEG) die bakterielle Adhäsion von S. aureus-Zellen verhindern können. Die 
Vorbehandlung der EG3OMe und PEG Beschichtungen mit -Globulinen oder Serum 
führte jedoch zu einer starken Erhöhung der Adhäsion von S. aureus Zellen. Sowohl 
die spa-Deletionsmutante, als auch die Vorbehandlung von S. aureus mit Serum 
bewirken verminderte Adhäsion. Diese Ergebnisse legen nahe, dass die an die an 
die beschichteten Oberflächen gebundenen -Globuline die Adhäsion von S. aureus 
mittels Protein A vermitteln. Diese Adhäsion zu unterbinden könnte sich bei der 
Präventionen von Biofilmbildung als nützlich erweisen. 
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Part I Structure and Function of Yayureas from 
Staphylococcus intermedius group 
 
Introduction 
1. Quorum sensing (QS) 
Quorum sensing (QS) is a process of bacterial communication, first discovered in the 
marine photobacteria Vibrio fischeri (Nealson et al., 1970). The signal transduction of 
QS is mediated through the synthesis and secretion of small membrane-diffusible 
hormone-like molecules termed autoinducers. When they accumulate and reach a 
critical threshold, autoinducers bind to cognate receptors and trigger QS-regulated 
gene expression. The signal-activated receptor directly or indirectly controls the 
expression of target genes. Since the concentration of signaling molecules in liquid 
culture is proportional to cell density, gene expression is regulated in response to 
bacterial population densities (Atkinson and Williams, 2009; Waters and Bassler, 
2005). QS empowers bacteria to coordinate pathogenicity, cell division (Swift et al., 
1996), sporulation (Jabbari et al., 2011), conjugation (White and Winans, 2007), 
biofilm formation, swarming, toxin production (Falcao et al., 2004), bioluminescence 
(Miyamoto et al., 2000) and production of secondary metabolites (Swift et al., 1996) 
to rapidly respond to the environment. 
 
There is growing interest in utilizing QS as a new prospective therapy against 
bacterial infection, as the evolutionary pressure to develop drug resistance with QS 
inhibitor treatment is less strong. In contrast to classic antibiotics, quorum-quenching 
compounds are inhibitors of bacterial virulence, rather than of bacterial growth 
(Cegelski et al., 2008), and therefore might serve as promising anti-virulence 
therapies (Atkinson and Williams, 2009; Njoroge and Sperandio, 2009). Following 
studies on halogenated furanones, well-known QS inhibitors from the red marine 
alga Delisea pulchra (Gram et al., 1996; Manefield et al., 2001; Rasmussen et al., 
2000), screening for potential QS inhibitors has led to the discovery of many 
compounds with drug development potential (Table 1) (Gonzalez and Keshavan, 
2006). 
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Table 1. Chemical structures of quorum sensing inhibitors 
Names Source Structure  Active against 
Furanones 
(Gram et al., 
1996) 
 
 
 
 
 
Delisea 
pulchra 
  
 
P. aeruginosa 
Cyclo-L-proline-
L-tyrosine  
(Teasdale et al., 
2011) 
 
Bacillus 
cereus D28  
 
 
V. harveyi  
N-(2’-
phenylethyl)-
isobutyramide  
 
3-methyl-N-(2’-
phenylethyl)-
butyramide  
(Teasdale et al., 
2009) 
 
Halobacillus 
salinus C42 
 
 
V. harveyi 
and C. 
violaceum 
Malabaricone C 
(Chong et al., 
2011) 
 
 
Myristica 
cinnamomea 
  
C. violaceum 
and P. 
aeruginosa 
Ajoene 
(Bjarnsholt et 
al., 2005) 
 
 
Garlic 
alliinase 
 
P. aeruginosa 
and V. 
harveyi 
Penicillic acid 
 
Patulin 
(Rasmussen et 
al., 2005) 
 
 
 
 
Penicillium 
coprobium 
 
P. aeruginosa 
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2. QS systems of Gram-negative bacteria 
The first QS circuit was discovered in V. fischeri, and was responsible for population 
density dependent bioluminescence. The autoinducer (3-oxo-C6-homoserine 
lactone), which is synthesized by LuxI, binds to the LuxR protein and activates the 
lux operon producing the bioluminescence. In V. harveyi, the QS system consists of 
three autoinducers and three cognate receptors functioning in parallel to channel 
information into a shared regulatory pathway (Waters and Bassler, 2005). Similar to 
V. fischeri, V. harveyi produces an AHL signal termed HAI-1 (3-hydroxy-C4-
homoserine lactone) (Hanzelka et al., 1999) which binds to a membrane-bound 
sensor histidine kinase (LuxN). The second autoinducer molecule is AI-2, a furanosyl 
borate diester, which binds to the periplasmic protein LuxP. The LuxP-AI-2 complex 
then interacts with another membrane-bound sensor histidine kinase known as 
LuxQ. The third autoinducer molecule is termed CAI-1 (cholera autoinducer-1), a 
long chain ketone (Chen et al., 2002; Higgins et al., 2007), which is recognized by 
the membrane-bound sensor histidine kinase CqsS (Henke and Bassler, 2004). At 
low cell density, and in the absence of appreciable levels of autoinducers, the three 
sensors (LuxN, LuxQ, and CqsS) act as autophosphorylating kinases that 
subsequently transfer the phosphate to the cytoplasmic protein LuxU, which then 
passes the phosphate to the DNA-binding response regulator protein LuxO 
(Freeman and Bassler, 1999a, b). Phosphorylated LuxO represses the master 
regulator of QS, LuxR, via the sigma factor σ54 and small regulatory RNAs (Lenz et 
al., 2004; Lilley and Bassler, 2000).  
 
P. aeruginosa is a common bacterium that causes diseases in humans and other 
animals. It is viable on and in medical equipment, causing cross-infections in 
hospitals, and is responsible for about one in ten hospital-acquired infections 
by Pseudomonas species. Pathogenicity is caused by several QS-controlled factors, 
such as exoenzymes, exotoxins, virulence factors, and biofilm formation. For 
example, the P. aeruginosa exotoxin A inactivates elongation factor 2 of eukaryotic 
cells, leading to translation inhibition. Biofilms protect P. aeruginosa from antibiotic 
treatment and enable chronic opportunistic infections. Similar to V. harveyi, P. 
aeruginosa coordinates the expression of nearly 10% of its genome through three 
hierarchically arranged QS systems, namely Las, Rhl and Pqs (Williams and 
Camara, 2009). Each system consists of enzymes involved in autoinducer synthesis 
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and the target regulator: LasI produces 3-oxo-C12-HSL for activation of LasR 
(Pearson et al., 1994), RhlI produces C4-HSL for the activation of RhlR (Latifi et al., 
1995; Pearson et al., 1995), and the biosynthetic enzymes PqsABCDE and PhnAB 
produce PQS (2-heptyl-3-hydroxy-4-quinolone) for activation of PqsR (Deziel et al., 
2004; Gallagher et al., 2002; McGrath et al., 2004). QS systems are also prevalent in 
many other Gram-negative bacteria, as shown in Table 2 (Dobretsov et al., 2009). 
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Table 2. QS systems in Gram-negative bacteria 
Organism Autoinducers Regulated processes, genes and 
compounds 
Aeromonas hydrophila C4-HSL Biofilms (Swift et al., 1999) 
Aeromonas salmonicida C4-HSL Exoproteases (Swift et al., 1997)  
Agrobacterium tumefaciens 3-oxo-C8-HSL Plasmid conjugation (Oger et al., 1998) 
Agrobacterium viciae 3-oxo-C16 Virulence (Zhu et al., 1997) 
Burkholderia cenocepacia C6-HSL Biofilms, swarming (Huber et al., 2001; 
Tomlin et al., 2005), protease 
(Lewenza et al., 1999) 
Chromobacterium violaceum C6-HSL Violacein (McClean et al., 1997), 
cyanide, exoenzyme (Chernin et al., 
1998) 
Erwinia chrysanthemi 3-oxo-C6-HSL Pectinases (Nasser et al., 1998) 
Erwinia stewartii 3-oxo-C6-HSL Exopolysaccharides (Beck von 
Bodman and Farrand, 1995) 
Pseudomonas aeruginosa 3-oxo-C12-
HSL 
Biofilms (Parsek and Greenberg, 
1999), exoenzymes, exotoxins, 
virulence, pyocyanin(Latifi et al., 1995) 
Pseudomonas aureofaciens C6-HSL Phenazines (Pierson et al., 1994), 
proteases (Zhang and Pierson, 2001) 
Rhizobium leguminosarum 3-hydro-C8-
HSL 
Stationary phase adaption (Thorne and 
Williams, 1999), Root nodulation 
(Rodelas et al., 1999) 
Serratia marcescens C6-HSL Prodigiosin (Thomson et al., 2000) 
Serratia liquefaciens C4-HSL Swarming, exozymes (Eberl et al., 
1999; Givskov et al., 1998) 
Xenorhabdus nematophilus 3-hydroxy-4-
HSL 
Virulence (Dunphy et al., 1997) 
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3. QS systems of Gram-positive bacteria 
In contrast to Gram-negative bacteria, many Gram-positive bacteria communicate 
using modified oligopeptides as signals, and “two-component”-type membrane-
bound sensor histidine kinases as receptors. In staphylococci there is only one 
known system that involves a QS signal, the agr QS system, which is composed of 
the agrABCD genes (Novick et al., 1995). The excreted signal is a thiolactone- or 
lactone-based peptide (AIP, autoinducer peptide) that mediates communication with 
other staphylococci in a cell density-dependent manner (Ji et al., 1997; Ji et al., 
2005; Lyon and Novick, 2004). Excreted AIP reverse-signals via a classical two-
component signaling module (AgrC, transmembrane receptor histidine kinase; AgrA, 
DNA binding response regulator), thereby autoinducing the expression of many 
extracellular virulence factors in a quorum sensing-dependent manner. At low cell 
density, the bacteria express protein factors that promote attachment and 
colonization, whereas at high cell density, the bacteria repress these traits and 
initiate secretion of toxins and proteases that are presumably required for 
dissemination. Agr is conserved throughout the staphylococci but has diverged 
within the genus. The S. epidermidis AIP is an octapeptide containing a thiolester 
linkage between the central cysteine and the C-terminal carboxyl group (Otto et al., 
1998), and is active at nanomolar concentrations. Cross-inhibition studies of AIPs 
between S. aureus and S. epidermidis revealed that most S. aureus subgroups are 
sensitive towards the S. epidermidis AIP. This indicates that quorum-sensing cross 
talk seems to be generally in favor of S. epidermidis, which might explain the 
predominance of S. epidermidis on the skin and in implant-associated infections 
(Otto et al., 1998). However, AIPs of the S. intermedius group species are lactone 
peptides containing a conserved hydroxyl group on a serine residue. Lactone-
peptides are not only used by Staphylococci, but also utilized by Enterococcus 
faecalis to activate gelatinase production, which is a QS-controlled virulence factor 
(Nakayama et al., 2001).  
 
 
4. Interphylum interference 
Intra-species communication in Gram-positive or Gram-negative bacteria has been 
well studied. However, most microorganisms constantly have to compete for 
resources in nature, to prevail against competitors from different species or phylums, 
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and to survive in hostile environments. Do Gram-positive bacteria or Gram-negative 
bacteria dominate in specific environments? What happens if staphylococci 
encounter other bacteria in the host or other environments? One of the most well-
known examples is when S. aureus encounters Pseudomonas in the lungs of cystic 
fibrosis (CF) patients. According to the Annual Cystic Fibrosis Patient Registry 
Report, S. aureus is the predominant respiratory bacterium in the first ten years of 
CF patients, after which P. aeruginosa gradually catches up as S. aureus is 
simultaneously suppressed. The mechanisms underlying the suppression of S. 
aureus in this co-infection most likely rely on an arsenal of small respiratory inhibitors, 
such as the phenazine, pyocyanin, hydrogen cyanide or quinoline N-oxides excreted 
by P. aeruginosa. These respiratory toxins act both against the commensal flora as 
well as host cells (Lau et al., 2004). P. aeruginosa itself is protected as it possesses 
a cyanide-insensitive terminal oxidase related to the cytochrome bd quinol oxidases 
(CioAB) (Cunningham et al., 1997). In S. aureus and other pathogenic species, the 
cytochrome bd quinol oxidase (CydAB) is inhibited by pyocyanin hydrogen cyanide 
(Voggu et al., 2006), but it is not completely suppressed, as a sub-population readily 
adapts to become small colony variants (SCV) that can withstand pyocyanin and 
hydrogen cyanide exposure (Biswas et al., 2009; Hoffman et al., 2006). These in 
vitro findings correlate well with the clinical outcome, showing that S. aureus SCVs 
that demonstrated hemin, thymidine, and/or menadione dependencies are highly 
prevalent in the respiratory secretions of CF patients, persist over extended periods, 
and contribute to S. aureus persistence in CF patients (Kahl et al., 1998). The 
aforementioned examples illustrate self-protection mechanisms that allow some 
bacterial species not only to prevail but also to persist in unfavorable habitats.  
 
Another method to ensure persistence in natural environments and to limit 
competition is by excreting antibiotics. This is utilized by some skin staphylococci, 
which produce so-called lantibiotics such as epidermin or gallidermin (Kellner et al., 
1988; Schnell et al., 1988). These lantibiotics inhibit a wide spectrum of Gram-
positive bacteria by interacting with lipid I, II, III and IV, thereby inhibiting cell wall 
and wall teichoic acid (WTA) biosynthesis (Bonelli et al., 2006; Brötz et al., 1998; 
Müller et al., 2012).  
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5. Aim of the study 
While studying the potential interactions of Staphylococcus aureus and 
Staphylococcus carnosus with Gram-negative bacteria (Biswas et al., 2009; Voggu 
et al., 2006), we came across a communication system in another Staphylococcus 
species group, named 'intermedius group'. This group consists of closely related, 
mainly coagulase-positive bacterial species, including S. delphini, S. intermedius, S. 
lutrae, S. pseudintermedius, and S. schleiferi. They are all zoonotic pathogens, and 
only rarely infect humans.  
 
In the first part of the study, we found that these species excrete two small 
compounds that inhibit the expression of QS-controlled toxins and other QS-
regulated factors in Gram-negative bacteria.  
 
Our aim was to gain insight into the structure and function of these two compounds.  
 
One of the first milestones was the purification and subsequent identification of the 
structure of these two excreted compounds in cooperation with Prof. Dr. Stephanie 
Grond from the organic chemistry department in Tübingen. Once this was achieved, 
we then sought to chemically synthesize these compounds on a large scale, in order 
to study their function against Gram-negative bacteria. 
 
This study revealed two excreted compounds (yayurea A and yayurea B) that 
represent new bacterial products capable of quenching QS regulation in a wide 
spectrum of Gram-negative bacteria. Furthermore, growth of yayurea A- and B-
producing strains is not suppressed by respiratory toxins when co-cultured with P. 
aeruginosa. This suggests that the quorum quenchers have a function in self-
protection and competitiveness in natural environments shared with Gram-negatives. 
We show here an example of inter-phylum interference between firmicutes (Gram-
positive bacteria) and the beta- and gamma-proteobacteria (Gram-negative bacteria) 
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Results 
1. Structural elucidation of QS-inhibiting compounds from S. delphini 
First, we tested the ability of several staphylococcal species onto inhibit pyocyanin 
production of P. aeruginosa pyocyanin production in a co-cultivation assay, as 
pyocyanin production is QS controlled. We found that S. delphini DSMZ 20771 
completely inhibited pyocyanin production over 24 h in co-cultivation with P. 
aeruginosa PAO1, while Staphylococcus aureus showed no such activity (Fig. 1A). 
This led us to assess if S. delphini could also suppress QS-controlled phenotypes in 
other Gram-negative bacteria, such as QS-regulated prodigiosin production in 
Serratia marcescens (Thomson et al., 2000); bioluminescence in Vibrio harveyi 
(Anetzberger et al., 2009; Freeman and Bassler, 1999a); or violacein production in 
Chromobacterium subtsugae, a pathogen of potato beetles (Martin et al., 2007). 
Indeed, in co-cultivation studies with these Gram-negative bacteria, S. delphini did 
also suppress prodigiosin and violacein production, as well as bioluminescence, 
while S. aureus did not (Fig. 1BCD). Sterile filtered culture supernatant of a 24 h S. 
delphini culture had the same QS-inhibiting effect as the co-culture, indicating that 
the QS-inhibiting compound(s) were excreted. The supernatants of S. aureus and S. 
epidermidis caused no effect.  
 
To determine the approximate molecular mass of excreted compound(s), filtered 
supernatants of S. aureus and S. delphini were passed through molecular mass cut-
off filters and analyzed for pigment suppression activities in S. marcescens. The 
supernatant from S. delphini maintained activity after filtration through a 3-kDa 
molecular weight cut-off membrane (Fig. 2). To derive more chemical properties, the 
supernatant was further treated with heat, proteinase K, acid, or alkali for 1 h. 
However, the activity was not affected by any treatment (Fig. 2), demonstrating that 
the QS inhibitor(s) in question are small (below 3 kDa), pH- and heat-stable 
compound(s) that may not be protein-based. 
15 
 
 
Figure 1. Quenching of QS-regulated pigments and bioluminescence by S. 
delphini  
P. aeruginosa (A), S. marcescens (B), V. harveyi (C) and C. subtsugae (D) were 
each co-cultivated with S. aureus (1) or S. delphini (2) for 24 h. Pyocyanin, which is 
excreted by P. aeruginosa, was assessed in the supernatant at its absorption 
maximum A520nm. Prodigiosin, which is cell wall-bound in S. marcescens, was 
ethanol-extracted from the cell pellet and determined at its absorption maximum 
A534nm. Bioluminescence of V. harveyi was intensified by aeration before 
measurement in a bioluminescence reader. Violacein from C. subtsugae was 
quantitatively extracted with butanol and assessedd at its absorption maximum 
A585nm.  
 
Figure 2. Characterization of the active compounds of S. delphini supernatant 
S. aureus (SA) and S. delphini (SD) were cultured in TSB for 24 h. The supernatants 
were collected (1) and dialyzed with 3-kDa cutoff membrane (2-6). The supernatants 
were further treated with heat (95 oC) (3), 4 μg/μl Proteinase K (4), 10N HCl (5) or 
10N NaOH (6) for 1 h. All supernatants had pH values adjusted to 7, and were 
incubated with S. marcescens for 24 h. 
 
 
Reversed phase preparative (RP-HPLC) analysis of S. delphini supernatant showed 
the active compound(s) had a retention time (Rt) of 4 to 5 minutes which contained 
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two absorption signals at 210 nm (Fig. 3). At the same time, comparison of the RP-
HPLC profiles of S. aureus with S. delphini showed that these two absorption peaks 
(peak 2 and 4) were only seen in the supernatant of S. delphini (Fig. 4). The data 
implies that these two absorption peaks might be the QS inhibitors in question. To 
purify the active compounds, several purification steps were performed (Fig. 5 and 
6). The purification process revealed that the supernatant contained two compounds 
with different retention times (Rt) in HPLC and distinct UV spectra. We subsequently 
named the two compounds yayurea A and B.  
 
 
 
Figure 3. Location of the active compound within the HPLC profile of S. 
delphini supernatant 
The supernatant of S. delphini was analyzed and separated into 10 fractions by RP-
HPLC. The collected fractions were lyophilized, resuspended by water and 
inoculated with S. marcescens for 24 h.  
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Figure 4. RP-HPLC profile comparison of S. aureus and S. delphini 
RP-HPLC profiles of the culture supernatants of S. delphini (B) showing the 
production progression of yayurea B and yayurea A (peaks 2 and 4) at 2 h, 6 h and 
24 h in comparison to the non-producing S. aureus (A). HPLC analysis was carried 
out on an Agilent 1200 and Waters xBridge C18, 5 μm, 4.6x150 mm column. Elution 
was made with a 15 min linear gradient of 0.1% Phosphoric to acetonitrile at a flow 
rate of 1.5 ml/min. 
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Figure 5. Outline of the compound purification procedures 
The supernatant of S. delphini was collected and applied to different resins in the 
order shown above. The elutions of each step were collected and tested for QS 
inhibition activity with S. marcescens. The fractions with no QS inhibition activity 
were discarded; the fractions with QS inhibition activity were moved on to the 
following procedure. 
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Figure 6. Purification of QS-inhibitors 
(A) S. delphini supernatant was applied to a column filled with an Amberilite XAD-16 
resin. The column was washed with water and eluted with 0% to 100% MeOH. The 
collected fractions were lyophilized, resuspended by water, and inoculated with S. 
marcescens for 24 h. (B) The eluates by 80% MeOH and 100% MeOH from XAD-16 
resin were applied to a column filled with Amberilite IRC-50 cation exchange resin. 
The column was washed with 70% EtOH and eluted with 80% EtOH acidified with 
5% acetic acid. (C) The eluate was further separated on a SP Sepharose cation 
exchange column with a linear 1 M NaCl gradient in 50 mM sodium phosphate buffer. 
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The two active compounds were eluted separately. (D) The final purification and 
desalting of each peak was carried out by RP-HPLC on a nucleosil 100 C-18, 8×250 
mm column with a linear water acetonitrile (containing 0.1% TFA) gradient of 0% to 
60% in 25 min. (M. Nega, MSc thesis) 
 
 
Yayurea A (indole-ethylurea) was isolated as a brownish solid, and revealed an ion 
peak at m/z = 161 ([M+H]+) in ESI-MS (Fig. 7A), while the molecular formula, 
C10H13N2, was revealed in FT-ICR-MS analysis. The 1H-indole-3-ethylamine moiety 
was deduced from GC-EI-MS (Rt = 29.0 min). 1H-NMR spectra showed a 
characteristic singlet at H = 8.55 ppm (Fig. 8A). The remaining signals were 
assigned to 2-(3-indoyl) ethylamine. The 13C-NMR spectrum and additional HSQC 
experiments displayed signals pointing to a carbonyl group at  = 170.5 ppm (Fig. 
8B), five methin groups, and two methylene groups to reveal a urea moiety. 
Additionally, 2D NMR experiments supported the structure of yayurea A as N-[2-(1H-
indole-3-yl) ethyl]-urea (Fig. 9A). Yayurea B (phenethylurea) was obtained as a 
colorless solid. A preliminary molecular formula, C8H10N, was deduced from the FT-
ICR-MS spectrum, which showed an ion at m/z = 121 ([M+H]+) (Fig. 7B). GC-EI-MS 
provided a signal at Rt = 15.0 min pointing to 2-phenethylamine. The 1H-NMR again 
showed a set of aromatic protons and a singlet at H = 8.54 ppm (Fig. 8C), while the 
13C-NMR displayed a signal at H = 170.4 ppm (C=O) and five aromatic and 4 
aliphatic protons (Fig. 8D). In summary, the structure of N-(2-phenethyl)-urea was 
assigned for yayurea B (Fig. 9B). UV-absorption maxima emphasized the phenyl 
( = 260 nm) and indole chromophores ( = 225 nm and  = 280 nm respectively) of 
the yayureas. Comprehensive physicochemical characteristics of yayurea A and B 
are shown as follows (Table 3).  
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Figure 7. Mass spectra of the two QS-inhibitors purified from S. delphini  
Mass spectrometry was carried out on GC-MS and FT-ICR MS (Bruker, ApexII). 
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Figure 8. NMR spectra of the QS inhibitors purified from S. delphini 
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1H-NMR-spectrum (600 MHz, MeOD) of yayurea A (A) and yayurea B (C). 13C-NMR-
spectrum (150 MHz, MeOD) of yayurea A (B) and yayurea B (D). (Wöfle et al. 
unpublished). 
Figure 9. RP-HPLC profile, UV spectrum, and structures of the two QS-
inhibitors purified from S. delphini  
(A) QS-inhibitor, N-[2-(1H-indol-3-yl)ethyl]-urea (yayurea A). (B) QS-inhibitor, N-(2-
phenethyl)-urea (yayurea B). RP-HPLC was carried out on an Agilent 1200 and 
Waters xBridge C18, 5 mm, 4.6x150 mm column; compounds were eluted with a 15 
min linear gradient of 0.1% phosphoric acid to acetonitrile at a flow rate of 1.5 ml/min.  
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Table 3. Physicochemical characteristics of yayurea A and B 
 
 
Yayurea A and B were also chemically synthesized and their identities confirmed by 
mass spectrometry and NMR analyses (Wölfle et al. manuscript in preparation). Both 
the synthesized and the natural compounds revealed the same chemical properties, 
such as retention time and UV absorption (Fig. 10 and 11), and had the same QS-
quenching activity in Gram-negative bacteria (data not shown). 
  
 
N-[2-(1H-indol-3-yl)ethyl]-urea 
(yayurea A) 
N-(2-phenethyl)-urea     
(yayurea B) 
Formula C11H13O1N3 (203.24 g/mol)  C9H11O1N2 (163.20 g/mol)  
Melting 
point 
240.8 °C 214.9 °C 
Rf-values 0.10 (CHCl3/MeOH 9:1)  
0.63 (MeOH/H2O 7:3)  
0.28 (CHCl3/MeOH 9:1)  
0.94 (MeOH/H2O 7:3)  
1H NMR 
(600 MHz, MeOH-d4) d 3.11 (t, 
J = 7.0, 7.4 Hz, 2H), 3.22 (t, 
J = 7.1, 7.3 Hz, 2H), 7.04 (dd, 
J = 7.4, 7.5 Hz, 1H), 7.13 (dd, 
J = 7.7, 7.9 Hz, 1H), 7.17 (s, 1H), 
7.37 (d, J = 8.2 Hz, 1H), 7.57 (d, 
J = 7.9 Hz, 1H), 8.55 (s, 1H). 
(600 MHz, MeOH-d4) d 2.95 (t, 
J = 7.4, 8.1 Hz, 2H), 3.16 (t, J= 7.4, 
8.1 Hz, 2H), 7.28 (m, 3H), 7.35 (m, 
2H), 8.54 (s, 1H). 
13C NMR (150 MHz, MeOH-d4) d 24.9, 
41.5, 110.6, 112.7, 119.0, 120.2, 
122.9, 124.4, 128.4, 138.5, 170.5. 
(150 MHz, MeOH-d4) d 34.9, 42.1, 
128.4, 129.9, 130.2, 138.1, 170.2. 
MS (ESI) 
(Positive ions) m/z (%) [M+2H-
CONH2]+ 161.11. 
(Positive ions) m/z (%) [M+2H-
CONH2]+ 122.10.  
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Figure 10. Comparison of purified and synthetic yayurea A 
The RP-HPLC profiles of purified (A) and synthetic (B) yayurea A. The overlapped 
RP-HPLC (C) and UV-Vis spectrum (D).   
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Figure 11. Comparison of purified and synthetic yayurea B  
The RP-HPLC profiles of purified (A) and synthetic (B) yayurea B. The overlapped 
RP-HPLC (C) and UV-Vis spectrum (D).   
 
 
In Fig. 4, both S. aureus and S. delphini showed absorption peak 1 and 3 at the 
beginning of the culture. The amounts of peak 1 and peak 3 were not changed in S. 
aureus, but were reduced in S. delphini over time. Interestingly, as peak 1 and peak 
3 decreased, yayurea A and B (peak 4 and 2 respectively) increased (Fig. 4B). We 
speculated if the peak 1 and 3 were precursors for the yayureas? After separation, 
these two peaks were analyzed by GC-MS and FT-ICR MS. The results of MS 
showed that peak 1 is phenylalanine and peak 3 is tryptophan, which were already 
present in the culture medium (data not shown). To verify the above hypothesis, S. 
delphini was fed with phenylalanine, tryptophan, or tyrosine after 6h, and the 
production of yayureas were quantified until 72 h. Yayurea A increased up to 300% 
and 400% with 0.1 mg/ml and 0.3 mg/ml tryptophan, but did not change with 
phenylalanine or tyrosine administration (Fig.12A). In contrast to yayurea A, adding 
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0.1 mg/ml and 0.3 mg/ml phenylalanine enhanced yayurea B to 180% and 240%, 
respectively (Fig.12B). 
 
 
Figure 12. Precursor analysis of yayureas 
S. delphini was grown in TSB at 37°C. Cultures were fed with phenylalanine (Phe), 
tryptophan (Trp), or tyrosine (Tyr) in different concentrations after 6 h. Arrows 
indicate time point of amino acid feeding. Water was used as a control and the 
yayurea amount at 24 h was set as 100%. Production of yayurea A (A) and B (B) 
were measured by HPLC. 
 
 
2. Biological properties of yayureas 
a) Suppression of respiratory toxins protects from killing by P. aeruginosa 
P. aeruginosa produces various QS-controlled respiratory toxins, such as pyocyanin 
and hydrogen cyanide (Castric, 1975; Hassan and Fridovich, 1980), which kill S. 
aureus (Biswas et al., 2009). If yayurea A and B repress the production of QS-
regulated pyocyanin or hydrogen cyanide, one would expect that S. delphini survives 
better in a co-culture with P. aeruginosa than, for example, S. aureus. Indeed, co-
cultivation studies with S. aureus (non-producer) or S. delphini with P. aeruginosa 
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SH1 revealed that the viability (CFU) of S. aureus significantly decreased in the 
stationary growth phase, most likely due to the respiratory toxins produced by P. 
aeruginosa (Fig. 13A), while that of S. delphini was uninfluenced (Fig. 13B). The 
addition of yayurea A and B to the mixed S. aureus and P. aeruginosa culture 
protected S. aureus from killing in the stationary phase (Fig. 13A). Furthermore, the 
CFU of P. aeruginosa SH1 was unaffected when co-cultured with S. delphini or S. 
aureus, indicating that none of the two staphylococcal species was able to kill P. 
aeruginosa. Co-cultivation of P. aeruginosa with S. aureus in the presence of 
yayureas (100 µg/ml yayurea A and 900 µg/ml yayurea B) also had no effect on the 
viability of P. aeruginosa (Fig 13C). Other tested Pseudomonas strains, PAO1 and 
DSMZ 50071, showed similar results (data not shown). All in all, these results 
showed that production of yayurea A and B enables staphylococci to coexist with 
Gram-negative bacteria in a mixed community.  
 
Figure 13. Survival of staphylococcal strains in mixed culture with P. 
aeruginosa 
(A) CFU of S. aureus alone (SA) and in co-culture with P. aeruginosa (SA+PA). For 
the protection test, yayurea A (100 µg/ml) and B (900 µg/ml) were added to the 
mixture of S. aureus and P. aeruginosa (SA+PA+yayurea A/B). (B) CFU of S. 
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delphini alone (SD) and in co-culture with P. aeruginosa (SD+PA). (C) CFU of P. 
aeruginosa SH1 co-cultured with S. aureus (PA+SA), yayureas (PA+SA+yayurea 
A/B) or S. delphini (PA+SD). Values represent the means of three independent 
experiments. Bars indicate mean standard deviation, SD. 
 
 
b) Yayurea A and B are mainly produced in stationary growth phase 
We followed the production of yayurea A and B over 24 h in the supernatant of S. 
delphini cultured in TSB. Production levels of yayurea A and B were determined by 
HPLC-analysis; peak integration was correlated with standard yayurea A and B. The 
production of both compounds started at the transition of exponential to stationary 
growth phase (after approximately 4 h) and increased rapidly for the next 5 h; after 
24 h little was produced (Fig. 14). The production kinetics are reminiscent of QS-
controlled expression. Both compounds were produced in amazingly high 
concentrations: yayurea A reached concentrations of 120 µg/ml and yayurea B 
reached levels up to 900 µg/ml. This high concentration is entirely sufficient to 
suppress QS systems in Gram-negative bacteria, as can be seen below.  
       
 
Figure 14. Quantification of yayurea A and B production in relation to growth 
S. delphini was grown in TSB at 37°C. Supernatant was collected and OD578 was 
measured hourly for the first 9 h and after 24 h. Amounts of yayurea A and B in 
supernatants were quantified by triplicate HPLC measurements. Bars indicate mean 
standard deviation, SD. 
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c) Yayurea A is more active in inhibiting various QS-controlled traits in Gram-
negative 
Purified yayurea A and B inhibited QS-regulated factors in Gram-negative bacteria in 
a dose-dependent manner. We tested prodigiosin production in S. marcescens, 
bioluminescence in V. harveyi, and pyocyanin production in P. aeruginosa (Fig. 15 
and 16). Yayurea A and B inhibited production of prodigiosin in S. marcescens in a 
dose-dependent manner. Inhibition began at low concentrations (15 µg/ml) and 
increased with rising concentrations of yayurea A or B. At 250 µg/ml, prodigiosin 
production was inhibited at 60% (yayurea A) and 40% (yayurea B). At a 
concentration of 1,000 µg/ml, prodigiosin production was completely inhibited by 
yayurea A, and approximately 70% by yayurea B (Fig. 15A). At 500 μg/ml, 
bioluminescence of V. harveyi was inhibited by yayurea A and B by 99% and 76%, 
respectively (Fig. 15B). We also investigated whether yayurea A and B inhibited 
biofilm formation in P. aeruginosa and S. aureus. Again, yayurea A quite efficiently 
inhibited biofilm formation in P. aeruginosa, while yayurea B was less effective (Fig. 
15C). In contrast to gallidermin, a proven biofilm inhibitor in staphylococci (Saising et 
al., 2012), both yayureas showed no biofilm-inhibiting effect with S. aureus (Fig. 
15D). 
 
 
 
 
31 
 
 
Figure 15. Concentration-dependent inhibition of QS-regulated phenotypes in 
Gram-negative bacteria  
(A) Prodigiosin production in S. marcescens. Cells were grown in MB medium with 
serial dilutions of yayurea A or B at 28°C. Relative prodigiosin production was 
calculated as the ratio between prodigiosin content (absorbance at 534 nm) and cell 
density (absorbance at 600 nm). (B) Bioluminescence in V. harveyi. Cells were 
grown in marine broth with serial dilutions of compounds at 28°C for 24 h. Relative 
luminescence units were normalized by cell density. (C) Biofilm formation of P. 
aeruginosa. Cells were grown in LB with serial dilutions of yayurea A or B at 37°C for 
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24h. (D) Biofilm formation of S. aureus. Cells were grown in TSB with serial dilutions 
of yayurea A, B, or gallidermin (positive control) at 37°C for 24 h. Biofilm cell layers 
were visualized by crystal violet staining and measured at 590 nm. Microtiter plates 
presented are representative of at least three independent sets of experiments. Bars 
indicate standard deviation of the mean, SD. 
 
 
d) Yayureas have antimicrobial effect 
We noticed that high doses of yayurea A and B (especially yayurea A) inhibited the 
growth of Gram-negative bacteria. We used P. aeruginosa as an example to verify 
the effect of growth and QS inhibition by yayurea A and B, and used the antibiotic 
tetracycline and the well-known QS-inhibitor furanone (Hentzer et al., 2003) as 
controls (Fig 16). For QS inhibition, only 50% of the yayurea A and B concentration 
was necessary, as compared to concentrations needed for growth inhibition (Fig. 16 
A, B). Furanone revealed a similar correlation of growth and QS inhibition; 
concentrations (31 µg/ml) that inhibited 40% of growth inhibited 80% of QS (Fig. 
16C). In contrast to yayurea and furanone, tetracycline inhibited growth and QS in a 
near-linear fashion (Fig. 16D). Besides P. aeruginosa, yayureas also affected growth 
in S. marcescens, V. harveyi, and V. cholerae (Fig. 17); however, the growth of E. 
coli was not affected. All staphylococcal species tested, such as S. aureus, S. 
carnosus, S. delphini or S. schleiferi, were resistant to yayurea A and B, which was 
independent of their respective ability to produce these compounds. 
33 
 
 
Figure 16. Concentration-dependent inhibition of pyocyanin production and 
growth of P. aeruginosa  
P. aeruginosa PAO1 was grown in LB at 30°C with serial dilutions of yayurea A (A), 
yayurea B (B), furanone (C) and tetracycline (D). Relative pyocyanin production was 
calculated as the ratio between pyocyanin content and cell density (absorbance at 
600 nm). Values represent the means of three independent experiments. Bars 
indicate standard deviation of the mean, SD. 
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Figure 17. Influence of yayurea A and B on growth 
Growth curve of S. marcescens, P. aeruginosa, V. harveyi and V. cholerae in BM 
with 1,000 μg/ml yayurea A or B, or an equal volume of water. Arrows indicate time 
points (after 2h) of compound addition to the growing cultures. All the measurements 
were made in triplicate. Bars indicate standard deviation, SD. 
 
 
e) Yayurea A and B are perceived by the AHL-receptor LuxN of Vibrio harveyi 
To gain insight into the molecular mechanisms underlying the decrease in 
bioluminescence of V. harveyi caused by yayurea A and B, we performed in vitro 
phosphorylation assays of the signaling proteins involved. The full-length hybrid 
kinases LuxN, LuxQ, CqsS (tagged with 6 histidine residues) were heterologously 
expressed in an E. coli strain that lacks the F1/Fo-ATPase (to prevent ATP 
degradation during phosphorylation experiments), and inverted membrane vesicles 
prepared from this strain were directly used for the phosphorylation experiments. 
Then we tested the effect of yayurea A and B on the LuxN, LuxQ [in interplay with 
LuxP (LuxPQ)], and CqsS-mediated time-dependent phosphorylation of the HPt 
protein LuxU (Fig. 18A). Yayurea A and B had no effect on LuxPQ or CqsS-
mediated phosphorylation of LuxU (Fig. 18B). However, they significantly stimulated 
35 
 
the LuxN-mediated phosphorylation of LuxU in comparison to the control (Fig. 18C, 
compare lane 2 with lanes 4 and 10). LuxN is the sensor for the AHL autoinducer 
N-(3-hydroxybutyryl)-homoserine lactone (HAI-1) (Fig. 18A). It is known that the 
presence of HAI-1 inhibits the autophosphorylation activity of LuxN, thus decreasing 
the level of phospho-LuxU (Fig. 18C, compare lanes 2 and 6).  
Yayurea A and B caused the opposite effect, leading to an increase in the level of 
phospho-LuxU, which explains the decrease in bioluminescence when V. harveyi is 
exposed to these compounds. Under our test conditions, autoinducer HAI-1 was 
dominant in relation to yayurea A or B (Fig. 18C, compare lane 4 with lanes 8 and 
12). Taken together, these data show that the receptor kinase LuxN of V. harveyi 
specifically recognizes yayurea A and B. It is still unclear whether yayurea A and B 
also bind to the HAI-1 binding site, or whether LuxN contains an independent binding 
site for these novel compounds.  
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Figure 18. Yayurea A and B affect the V. harveyi LuxN receptor 
(A) Schematic representation of the QS phosphorelay in V. harveyi. In the absence 
of autoinducers (HAI-1, AI-2 and CAI-1) at low cell density, each of the three 
receptors, LuxN, LuxQ and CqsS, respectively autophosphorylates at a conserved 
histidine of their histidine kinase domain (HK). The phosphoryl group is first 
transferred to the receiver domain (Rec) of the receptor kinase and then to the HPt 
protein LuxU. LuxP is a periplasmic binding protein. P denotes phosphorylation sites. 
Upon perception of the autoinducers at high cell density, autophosphorylation of the 
receptors and the subsequent phosphosphrylation cascade is inhibited. Yayurea A 
and B stimulated the phosphorylation of the cascade via LuxN. (B) LuxPQ and CqsS 
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mediated phosphorylation of LuxU in the presence of yayurea A and B. (C) LuxN 
mediated phosphorylation of LuxU in the presence of yayurea A and B and HAI-1. 
LuxQ, CqsS, LuxN-bearing membrane vesicles and LuxU, were incubated with 100 
M [-32P] ATP. The effect of yayurea A, B, and HAI-1 (C) on the initial rate of LuxU 
phosphorylation was evaluated. Each reaction was sampled and stopped at two 
different time points: after 1 and 10 minutes. Final concentrations were 20 µM for 
HAI-1, 1.1 mM for yayurea A and 1.3 mM yayurea B, which were reflective of the in 
vivo situation. Absence of HAI-1 or yayurea A or B is indicated by " ̶ ", while their 
presence is indicated by "+". 
 
f) Phylogenetic position of yayurea-producing species in the Staphylococcus 
taxa 
We tested a number of staphylococcal species via co-cultivation with P. aeruginosa 
and assessment of pyocyanin production suppression (Table 4). Only five species 
exerted such an activity: S. delphini, S. intermedius, S. lutrae, S. pseudintermedius, 
and S. schleiferi, and they all produced yayurea A and B, as determined by HPLC 
analysis. Based on 16S rRNA- and multilocus-sequence typing (MLST) the species 
were determined to be phylogenetically related, and are summarized in the 
'intermedius group' (Lamers et al., 2012) (Fig. 19). Typically, the species are 
coagulase-positive (with the exception of S. schleiferi subsp. schleiferi), and oxidase-
negative. Interestingly, they all colonize various animals, and many represent 
zoonotic pathogens (Bannoehr et al., 2007; Ben Zakour et al., 2012). None of the 
other listed staphylococcal species (not even the closely-related S. hyicus, S. 
chromogenes or S. muscae) inhibited QS systems in Gram-negative bacteria, nor 
did they produce yayurea A and B. 
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Table 4. Strains tested for QS-quenching activity and yayurea A and B production 
Strains                                                                                      QS-inhibition 
S. aureus RN4220 − 
S. aureus SA113 − 
S. aureus 8325-4 − 
S. aureus RN1 − 
S. aureus HG001 − 
S. aureus HG002 − 
S. aureus HG003 − 
S. aureus Newman − 
S. arlettae DSM 20672T − 
S. carnosus TM300 DSMZ 20501 − 
S. capitis subsp. capitis LK499 ATCC 27840 − 
S. caprae DSM 20608T − 
S. chromogenes DSM 20454T − 
S. cohnii subsp cohnii DSM20260 − 
S. condiment DSM 11674T − 
S. delphini DSM 20771 +++ 
S. epidermidis ATCC14990 − 
S. equorum subsp. equorum DSM 20674T − 
S. gallinarum DSM 20610T − 
S. muscae DSM 7068T − 
S. haemolyticus CCM2737 − 
S. hominis DSM 20328 − 
S. hyicus NCTC 10350 − 
S. intermedius CCM 5739 + 
S. lentus DSM 20352T − 
S. lugdunesis ATCC 43809 − 
S. lutrae DSM 10244T + 
S. pasteuri ATCC 51129 − 
S. pseudintermedius ED99 +++ 
S. saprophyticus subsp. saprophyticus DSM 200229 − 
S. schleiferi subsp. coagulans ATCC49545 ++ 
S. schleiferi subsp. schleiferi DSM 4807 +++ 
S. simulans MK148 ATCC 27848 − 
S. warneri DSM 20316T − 
S. xylosus DSM 20266 − 
(+), Species that produce yayurea A and B 
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Figure 19. Phylogenetic tree of Staphylococcus species 
The tree is based on 16S rRNA relationships according to (Götz et al., 2006). The 
phylogenetic position of the 'intermedius group', composed of S. intermedius, S. 
pseudintermedius, and S. delphini, is marked in bold. Based on a combination of 
16S rRNA and multilocus data, the group was recently complemented by the next-of-
kin species S. lutrae, S. schleiferi subsp. schleiferi, and S. schleiferi subsp. 
coagulans (Lamers et al., 2012). All members of this group produce yayurea A and B. 
 
 
3. Corresponding genes of yayureas 
To search the candidate genes involved in yayurea production, random transposon 
mutagenesis was performed with Tn917 delivery plasmid (pTV1ts) to construct pools 
of transposon mutants, each containing a unique insertion in S. schleiferi subsp. 
schleiferi. Supernatants of individual mutants were collected and their ability of 
repressing prodigiosin production in S. marcescens was tested. The colonies which 
lost prodigiosin-repressing activity were selected and analyzed for their transposon 
insertion site with LI-COR DNA sequencer (Table. 5). Four of the mutant clones had 
transposon insertions interrupting known Staphylococcus global regulatory loci, three 
of which were in the agr (accessory gene regulation) system (twice at agrC) and one 
of which was in the sar (staphylococcus accessory regulation). Additional three 
mutant clones had transposon insertions in transporter proteins, such as sodium 
alanine symporter, glutamate ABC transporter, and major facilitator family 
transporter, secondary carriers facilitating movement of small solutes in response to 
chemiosmotic ion gradients (Pao et al., 1998; Walmsley et al., 1998). Four other 
mutants had transposon insertions in known genes of transposase for ISSps1, 
metallo-β-lactamase superfamily protein, glycine dehydrogenase subunit 1, and PIN 
domain-containing membrane protein, the last of which had a nuclease enzyme 
function that could cleave single-strand RNA in prokaryotes (Arcus et al., 2011). Two 
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clones had insertions at unknown-function putative proteins. The genes which were 
only shown once in the pool were not likely the corresponding genes for yayurea. We 
believe agr- and sar system play an important role for biosynthesis of yayurea, 
especially the agr system. However, both systems regulate numbers of downstream 
genes which involved in extracellular toxins, cell surface proteins, enzymes and 
signaling pathway. Thus we have to extent the amount of mutants in this pool and 
screen more transposon mutants to demonstrate connection between agr system 
and yayureas. 
 
Table 5. Characterization of candidate clones 
Transposon insertion site Function 
agrA (accessory gene regulator A) response regulator of agr regulator system 
agrC (accessory gene regulator c) histidine protein kinase 
sarR (accessory regulator R) transcriptional regulator 
SACOL1392 sodium alanine symporter 
glutamine-binding periplasmic protein glutamate ABC transporter 
SPSE1456 major facilitator family transporter 
SPSE0435 Transposase for ISSps1 
SPSE2262  PIN domain-containing membrane protein 
SPSE0028 metallo-β-lactamase superfamily protein 
gcvPA glycine dehydrogenase subunit 1 
SPSE1358 putative membrane protein 
SPSE1216 unknown function protein 
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Figure 20. Schematic presentation of the interference between zoonotic 
staphylococcal species and Gram-negative bacteria 
Animal associated (zoonotic) Staphylococcus species excrete novel quorum-
quenching compounds, yayurea A and B, which block quorum sensing systems in 
various Gram-negative bacteria by activating LuxN phosphorylation, and also have 
growth-inhibiting activity. The benefit for staphylococcal species is better survival and 
increased competitiveness in a joint ecosystem.  
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Discussion 
We found that some staphylococcal species excrete novel compounds, yayurea A 
and B, which interfere with the QS system of diverse Gram-negative bacteria. We 
tested 24 staphylococcal species with respect to production of yayurea A and B, via 
co-cultivation with Gram-negative bacteria. The results showed only five species (S. 
delphini (Varaldo et al., 1988), S. intermedius (Hájek, 1976), S. pseudintermedius 
(van Duijkeren et al., 2011), S. lutrae (Foster et al., 1997), and S. schleiferi (Bes et 
al., 2002)) produced these compounds and were able to inhibit QS-regulated 
markers of Gram-negative bacteria. S. delphini was isolated from dolphins, camels, 
pigeons, and mustelidae (minks, ferrets and badgers), mostly in association with 
infection (Guardabassi et al., 2012; Sledge et al., 2010). S. pseudintermedius has 
been mainly isolated from dogs, but also from other animals (Devriese et al., 2009; 
Devriese et al., 2005). S. intermedius is prevalent in domestic pigeons and dogs 
(Cree and Noble, 1995; Hájek, 1976; Phillips and Kloos, 1981). S. lutrae was 
classified after isolation form otters (Foster et al., 1997). S. schleiferi was first 
described as a clinical isolate, but has been isolated from the external auditory 
meatus of dogs with external ear otitis (Bes et al., 2002; Freney et al., 1988; Igimi et 
al., 1990). All five species are naturally associated with various animals, where they 
act as zoonotic pathogens. They are only rarely associated with human infections. It 
is remarkable that these species were found to be clustered in various phylogenetic 
trees, based on either 16S rRNA (Götz et al., 2006; Takahashi et al., 1999), 
thermonuclease (nuc) sequences (Sasaki et al., 2010), major autolysin (atl) 
sequences (Albrecht et al., 2012), or multilocus sequence typing (MLST) (Lamers et 
al., 2012). The five species form a phylogenetic cluster, termed the "intermedius 
group" (Figure 19). 
 
The structures of yayureas and preliminary results suggest that they are derived 
respectively from phenylalanine and tryptophan (Fig. 12). Staphylococci are 
auxotrophic for a few amino acids; however, they are prototrophic for the aromatic 
amino acids (Rudin et al., 1974). There are two possibilities of how yayureas are 
synthesized: either the biosynthesis enzymes are part of the Trp- and Phe-
biosynthesis pathway, or Trp and Phe are first synthesized and then modified, 
perhaps involving a carbamoyl transferase reaction. Yayureas have been chemically 
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synthesized (Wöfle et al. unpublished). The structures of the synthetic compounds 
were identical to the naturally-produced compounds, with both groups showing the 
same activity (Figs. 10 and 11). 
 
The first described quorum-sensing system was in the bioluminescent marine 
bacterium Vibrio fischeri (Nealson and Hastings, 1979). Later, it was observed in 
Vibrio harveyi that bacteria can communicate through multiple quorum-sensing 
signals, and V. harveyi became one of the QS model bacteria. The V. harveyi 
quorum-sensing system consists of three autoinducers and three cognate receptors, 
functioning in parallel to channel information into a shared regulatory pathway 
(Waters and Bassler, 2005). Similar to other Gram-negative bacteria, V. harveyi 
produces an AHL signal termed AI-1 (3OHC4-homoserine lactone) (Hanzelka et al., 
1999), which binds to the membrane-bound sensor histidine kinase (LuxN). The 
second molecule is AI-2, a furanosyl borate diester, which binds to the periplasmic 
protein LuxP and the LuxP-AI-2 complex to interact with another membrane-bound 
sensor histidine kinase, LuxQ. The third molecule is termed CAI-1 (cholera 
autoinducer-1), an (S)-3-hydroxytridecan-4-one (Chen et al., 2002; Higgins et al., 
2007), which is recognized by the membrane-bound sensor histidine kinase CqsS 
(Henke and Bassler, 2004). At low cell density, in the absence of appreciable 
amounts of autoinducers, the three sensors (LuxN, LuxQ, and CqsS) act as 
autophosphorylating kinases that subsequently transfer the phosphate to the 
cytoplasmic protein LuxU, which passes the phosphate to the DNA-binding response 
regulator protein LuxO (Freeman and Bassler, 1999a, b). Phospho-LuxO, in 
conjunction with a transcription factor termed σ54, activates expression of five 
regulatory small RNAs (sRNAs) termed Qrr1–5 (Quorum Regulatory RNA) (Lenz et 
al., 2004; Lilley and Bassler, 2000), which indirectly repress the master regulator of 
quorum sensing, LuxR. Together, these communication systems act as a three-way 
coincidence detectors in the regulation of a variety of genes, including those 
responsible for bioluminescence, biofilm formation, type III secretion, or 
metalloprotease production (Henke and Bassler, 2004). To gain insight into the 
mode of QS quenching by yayurea A and B, we performed in vitro phosphorylation 
assays with the autoinducer receptors LuxN, LuxQ, CqsS (Fig. 18A). Yayurea A and 
B had no effect on LuxPQ or CqsS-mediated phosphorylation of LuxU. However, 
they significantly stimulated the LuxN-mediated phosphorylation of LuxU (Fig. 18B - 
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C), suggesting that they interact with LuxN and induce LuxU activation. While the 
LuxN autoinducer HAI-1, an AHL, inhibits the autophosphorylation of LuxN, 
consequently leading to a decrease in LuxU-phosphorylation, yayurea A and B 
induced the opposite effect by increasing LuxU phosphorylation. This suggests that 
yayurea A and B keep V. harveyi in a phenotypic state of low cell density, even 
though the cells have grown to high density in actuality. When both AI-1 and yayurea 
A or B were applied, HAI-1 overruled the effect of yayurea A and B in vitro. 
Bioluminescence of the wild type strain in vivo significantly decreased after exposure 
to yayurea A and B, although the effect of the latter compound was smaller. 
Obviously, HAI-1 did not overrule the effect of yayurea A and B in vivo. This 
difference can be explained by the fact that bioluminescence was measured in 
stationary phase cells. a time when the impact of HAI-1 on QS induction is low 
(Anetzberger et al., 2012). Furthermore, the contribution of the other receptors (LuxQ 
and CqsS) and their cognate autoinducers (AI-2 and CAI-1) needs to be considered 
in vivo (Anetzberger et al., 2012). The ratio of the three receptors and the impact of 
their kinase and phosphatase activities on the output of the phosphorylation cascade 
is not yet fully understood. This could be another explanation for the strong effect of 
the quorum quenchers in vivo. Membrane-topology analysis predicts that LuxN is 
bound to the bacterial inner-membrane by nine transmembrane (TM) spanning 
domains (Jung et al., 2007), and periplasmic loop 3 might be the HAI-1 binding site 
(Swem et al., 2008). We believe that yayurea A and B interfere with the AHL quorum 
sensing response of Gram-negative bacteria; since the tested bacteria on which the 
effects were observed have at least one AHL-based quorum sensing system 
(Pseudomonas, Chromobacterium, Vibrio, and Serratia).  
 
The in vitro phosphorylation assay provided initial mechanistic insights on how 
yayurea A and B affect quorum sensing of V. harveyi. We detected a significant and 
specific effect of yayurea A and B on the AHL-receptor LuxN. The concentrations 
used for these in vitro assays may not necessarily be similar to physiological levels, 
especially when the influence of both molecules (HAI-1 and yayurea) was studied. 
Furthermore, it should be noted that HAI-1 is not constantly produced (Anetzberger 
et al., 2012). Therefore, in the natural habitat there might be times when yayurea 
from S. delphini can fully interact with LuxN from V. harveyi in the absence of any 
competition with HAI-1. It therefore makes sense that the zoonotic staphylococci 
45 
 
impair the QS-system of Gram-negative bacteria for competitive reasons. We do not 
yet know whether Vibrio harveyi or Serratia marcescens excrete anti-staphylococcal 
compounds. However, P. aeruginosa excretes various respiratory toxins (e.g. 
pyocyanin and cyanide) that not only attack tissue cells but also inhibit growth of S. 
aureus (Lau et al., 2004; Ran et al., 2003; Voggu et al., 2006). The growth of 
zoonotic staphylococci is not impaired by P. aeruginosa because the excreted 
yayureas suppress the production of the QS-controlled toxins, and are thereby 
protected from being killed by the toxins (Fig. 13). While biofilm formation appears to 
be modulated by many regulators and environmental conditions in P. aeruginosa, 
pyocyanin and cyanide are controlled by the Las-QS system (Rampioni et al., 2007), 
implying that yayurea A and B might compete with 3-oxo-C12-HSL for LasR 
interaction.  
 
P. aeruginosa QS is hierarchically organized, since 3OC12-HSL is required for 
optimal production of the other QS signals (Heeb et al., 2011; Wilder et al., 2011). 
Both pyocyanin and cyanide inhibit the growth of S. aureus and other pathogenic 
staphylococci; however, pyocyanin was approximately 100 times more active than 
cyanide (Voggu et al., 2006). Pyocyanin, a phenazine antibiotic, is not only controlled 
by QS signaling (Deziel et al., 2004), but also by catabolite repression (crc), as its 
synthesis is 26-fold upregulated in crc mutants (Huang et al., 2012). The 
physiological function of pyocyanin is displayed predominantly during restricted 
growth and in the stationary phase (Price-Whelan et al., 2007). When yayurea A 
(125 µg/ml) was added, the growth of P. aeruginosa was not affected (Fig. 16A), but 
pyocyanin production and biofilm formation (Figs. 16A and 15C) were inhibited by 
20%, which indicates that biofilm inhibition takes place prior to the onset of growth 
inhibition. In addition to their quorum quenching activity in Gram-negative bacteria, 
yayureas also inhibited their growth at higher doses (Fig. 17), which is a further 
advantage in the race for space and resources. For this advantage the zoonotic 
staphylococci are apparently prepared to pay a certain price, namely the production 
and excretion of comparatively high amounts of yayurea A and B. However, the 
benefit in competitiveness appears to prevail over the cost disadvantages. As QS 
controls not only virulence factors but also many metabolic functions important for 
fitness, we do not know whether the inhibition of growth is a consequence of QS-
inhibition or vice versa (Dandekar et al., 2012; Heurlier et al., 2006; van Kessel et al., 
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2013). For some antibiotics (azithromycin, ceftazidime, and ciprofloxacin), it has 
been shown that they decrease the expression of QS-regulated virulence, as well as 
many other genes (Skindersoe et al., 2008). The yayureas are potential candidates 
for use as anti-infectives. The only disadvantage might be the rather high 
concentration needed to completely quench QS; on the other hand, preliminary 
results suggest that cytotoxic effects are minimal (Fig. 18). 
 
Most natural environments harbor a stunningly diverse collection of microbial species. 
There are not many Gram-positive bacteria able to produce secondary metabolites 
that inhibit quorum sensing-controlled phenotypes in various Gram-negative bacteria. 
One example is the marine bacterium Halobacillus salinus, which produces N-(2'-
phenylethyl)-isobutyramide and 2,3-methyl-N-(2'-phenylethyl)-butyramide (Teasdale 
et al., 2009). These compounds are similar but unrelated to yayurea A (N-[2-(1H-
indol-3-yl)ethyl]-urea) and B (N-(2-phenethyl)-urea). Within these communities, 
bacteria compete with their neighbors for space and resources (Hibbing et al., 2010). 
Zoonotic commensals and pathogens, including yayurea-producing staphylococcal 
species, use animals as a habitat. Whether these animals are also colonized by 
Gram-negative bacteria, other than in the gut, has barely been investigated. 
However, it is likely that animals bathe in puddles, lakes, and rivers, suggesting that 
their mucus, skin, fur, or feathers may easily encounter Gram-negative bacteria, 
being transient to permanent colonizers. It is also very likely that the 'intermedius 
group' share the habitat animal with Gram-negative bacteria. S. delphini was isolated 
from dolphins. Since both V. harveyi and S. delphini are marine bacteria and animal 
pathogens, it is conceivable that both bacteria share the same habitat and moreover, 
the same host surface. Our results demonstrated suppression of the quorum 
sensing-regulated bioluminescence of V. harveyi during co-culture with S. delphini 
(Fig. 1), indicating that yayurea A and B are effective quorum quenchers. 
Our study unveiled a number of interesting questions. First, what are the genes 
encoding the biosynthetic enzymes of yayurea A and yayurea B? The result of 
transposon mutagenesis suggested that yayureas are controlled by agr and sar, 
which are global regulatory systems in Staphylococci (Table. 6). We assume that 
special lactone peptides in the S. intermedius group (SIG) might regulate certain 
downstream genes that are controlled in different ways in S. aureus, which then 
trigger the biosynthetic pathway of yayureas. However, we still do not know what 
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these downstream genes are. Second, are there compounds with better effects than 
yayureas? According to this result and precursor tests in Fig. 12, it was suggested 
that the quorum quenching activity of yayureas may primarily depend upon the side 
chain. Moreover, AHLs in different species of Gram-negative bacteria vary in the 
length and composition of the acyl side chain of autoinducers (Taga and Bassler, 
2003), which also indicates that the acyl side chain plays an important role for 
biological activity. For further medical use, it is necessary to conduct more tests on 
yayureas and their derivatives in the future. Last but not least, why is yayurea 
production particular to the SIG, and what is the benefit for SIG? The most likely 
answer is that this group shares its habitat with Gram-negative bacteria. There must 
be a benefit to producing yayurea A and B because they are excreted in high 
amounts that certainly expend precious energy and resources. In addition, the 
yayureas show growth inhibition only at quantities that exceed the physiological 
concentrations. It is a clever arrangement, in that S. delphini produces just enough 
yayurea A and B to almost completely silence the expression of the studied QS-
regulated compounds or biofilm formation in diverse Gram-negative bacteria. In 
mixed cultures, the yayurea-producing staphylococci arrest Gram-negative bacteria 
in a pheno- and genotypic state of low cell density, although the cells have grown to 
high densities in actuality. The advantage for the staphylococci is twofold: on the one 
hand, they are protected from QS-controlled toxins, and on the other hand, yayurea 
A and B affect stationary growth of those Gram-negative bacteria with prominent QS-
control systems. This is one of the rare cases of inter-phylum interference between 
firmicutes (Gram-positive) and beta-/gamma-proteobacteria (Gram-negative). A 
schematic presentation of the interference is shown in Fig. 20. 
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Part II The role of protein A in Staphylococcus 
aureus adherence to ethylene glycol coated 
surfaces 
 
Introduction 
Biofilm formation is an important cause of chronic infections. The formation of biofilm 
involves in multiple steps, stating with a nonspecific and reversible attachment (Otto, 
2008). Once the biofilm is formed, the bacteria are nearly invulnerable as they are 
protected from the immune system and antibiotic treatment. Thus, it is very important 
to prevent biofilm formation and an effective way is to avoid the initial adhesion of 
microorganisms to the surface.  
 
In order to prevent microorganisms from building a biofilm, the surface should be 
very smooth or coated with some compounds. The widest used biofilm defense 
strategy on indwelling medical devices is chemical coating. Antimicrobial coatings 
such as antibiotics, ion- and biocide coating are often used to prevent biofilm 
formation(Dror et al., 2009). Another effective chemical coating are long and flexible 
polymeric chains which can be anchored to the surfaces by covalent bonds. Self-
assembled monolayer (SAMs) based surface coatings with oligo-ethylene-glycol 
(OEG) or poly-ethylene-glycol (PEG) terminations render surfaces resistant against 
non-specific protein adsorption and bacterial adhesion, which appears to be a 
promising approach (Pale-Grosdemange et al., 1991; Prime and Whitesides, 1993)  
 
In this study, we prepared OEG (EG3OMe) and PEG (PEG2k and PEG5k) coated 
surfaces that had good physicochemical properties in preventing S. aureus adhesion 
(Schilp et al., 2009). Pretreatment of EG3OMe and PEG coatings with -globulins or 
serum strongly promoted adherence of S. aureus when resuspended in buffer, 
suggesting that -globulins play a pivotal role in promoting S. aureus adhesion by its 
IgG binding proteins; the finding that a spa-deletion mutant, lacking the IgG binding 
protein A, showed decreased adherence corroborated this. 
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Results and discussion 
In cooperation with the research group of Dr. Fajun Zhang (Institut für Angewandte 
Physik, Universität Tübingen), the EG3OMe and PEG2k coated surfaces were tested 
for bacterial adhesion. The uncoated gold surface was heavily covered with S. 
aureus cells, while the EG3OMe and PEG2k coated surfaces were hardly covered 
with bacteria (Fig. 24 a, b and c). As implant material usually comes in contact with 
plasma components it is important to know what influence they have on bacterial 
adhesion. The coated surfaces were pre-incubated with PBS, bovine serum albumin 
(BSA), -globulins and bovine serum and tested for bacterial adhesion. When the 
coated surfaces were pre-incubated with BSA, there was no adherence of S. aureus, 
however, if pre-incubated with -globulins or bovine serum, the adhesion of S. 
aureus was significantly promoted (Fig. 24 d, e and f). Interestingly, we noticed that 
the amount of attached bacteria after pre-incubating with pure γ-globulins (60 mg/ml) 
was six-fold higher than that after pre-incubating with serum (the -globulins were 
about 10 mg/ml) (Fig. 24 d and e).  
The pretreatment of EG3OMe and PEG2k coatings with -globulins or bovine serum 
caused massive adhesion of S. aureus cells. We assume this might be due to that S. 
aureus harbors a high immunoglobulin-binding activity caused by its cell-wall bound 
protein A (Spa) (Löfdahl et al., 1983; Uhlen et al., 1984). The “second 
immunoglobulin-binding protein” (Sbi) is secreted and should not play a major role in 
adherence (Zhang et al., 1998). To prove this hypothesis, S. aureus SA113∆spa 
(pCX-pp-sfgfp), which is a Protein A deficient mutant strain, was used for the tests 
on uncoated gold or PEG5K coated surfaces. When the bacteria were resuspended 
in PBS buffer, the uncoated gold surface was heavily covered by the Wild-type (WT) 
and spa mutant strains (Fig. 25A1 and B1). If the strains were resuspended in buffer 
there was no adherence to the PEG5K coated surface (Fig. 25A2 and B2). When 
the PEG5K coated surface was pretreated with -globulins, the WT showed good 
adherence, whereas the ∆spa mutant did not adhere to surfaces (Fig. 25A3 and 
B3). In addition, we were interested to see if blocking Protein A would affect the 
bacterial adhesion. To address this question, S. aureus was resuspended in bovine 
serum and tested for its adherence on different coated surfaces. When the bacteria 
were resuspended in bovine serum, neither WT S. aureus nor ∆spa mutant adhered 
to the surfaces (Fig. 25A4 and B4).  
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Figure 21. Effect of S. aureus cells resuspended in PBS buffer on adherence to 
EG3OMe and PEG2k coated surfaces. Fluorescence microscopy images of S. 
aureus (pC-tuf-ppmCh) adhered on uncoated Au surface (a), EG3OMe coated 
surface (b), PEG2k coated surface (c) and EG3OMe coated surfaces pre-incubated 
with 20 mg/ml BSA (d), 50 mg/ml -globulins (e) or 100% bovine serum (f). (modified 
according to Yu et al. manuscript accepted) 
 
 
Figure 22. Comparison of S. aureus WT (A) and protein A mutant (B) on adherence. 
Fluorescence microscope images of S. aureus adhesion on uncoated gold (Au) 
surfaces (1), PEG5k coated (2) and PEG5k coated surfaces pre-incubated with 50 
mg/ml -globulins (3). Wafers were incubated with S. aureus SA113 WT (pC-tuf-gfp) 
or SA113∆spa (pCX-pp-sfgfp); cells were either resuspended in PBS (buffer) (1-3) or 
bovine serum (BS) (4).  
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Thus, our data demonstrated the adhesion of S. aureus cells on EG3OMe and PEG 
coatings and the effects pretreating these coatings with albumin, -globulins and 
serum. When coated with EG3OMe and PEG, the surfaces were hardly covered by 
bacteria (Fig. 21). However, pre-incubating EG3OMe and PEG coated surfaces with 
-globulins or serum strongly promoted S. aureus adhesion (Fig. 21). Comparisons 
of the adhesion of S. aureus WT with a protein A mutant showed that protein A 
played a crucial role in adherence when the coatings were pretreated with serum or 
-globulins (Fig. 22B3). The result of resuspending S. aureus with bovine serum also 
supported this hypothesis (Fig. 22B4). However, the interaction between -globulins 
and the coatings is still unknown. Are there special binding domains in -globulins 
that interact with the PEG and EG3OMe coatings? Is the Fc or the Fab part of IgG 
involved in mediating the binding to PEG and EG3OMe? These questions deserve 
future investigation. 
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Introduction
In many bacteria, pathogenicity is controlled and coordinated
by an inter-cellular communication process named quorum
sensing (QS). QS is based on the synthesis and secretion of small
hormone-like molecules termed autoinducers that bind to cognate
receptors. The signal-activated receptor controls directly or
indirectly expression of target genes. Since the concentration of
signaling molecules in liquid culture is proportional to cell density
in the culture, gene expression is coordinated in response to the
bacterial population density [1,2]. In V. harveyi, the QS system
consists of three autoinducers and three cognate receptors
functioning in parallel to channel information into a shared
regulatory pathway [2]. Similar to other Gram-negative bacteria,
V. harveyi produces an AHL signal termed HAI-1, 3-hydroxy-C4-
homoserine lactone [3], which binds to the membrane-bound
sensor histidine kinase (LuxN). The second molecule is AI-2, a
furanosyl borate diester, which binds to the periplasmic protein
LuxP. The LuxP-AI-2 complex interacts with another membrane-
bound sensor histidine kinase, LuxQ. The third molecule is termed
CAI-1 (for cholera autoinducer-1), a long chain ketone [4,5],
which is recognized by the membrane-bound sensor histidine
kinase, CqsS [6]. At low cell density, in the absence of appreciable
amounts of autoinducers, the three sensors (LuxN, LuxQ, and
CqsS) act as autophosphorylating kinases that subsequently
transfer the phosphate to the cytoplasmic protein LuxU, which
passes the phosphate to the DNA-binding response regulator
protein LuxO [7,8]. Phosphorylated LuxO represses the master
regulator of QS, LuxR, via sigma factor s54 and regulatory small
RNAs [9,10].
Similar to V. harveyi, P. aeruginosa coordinates the expression of
nearly 10% of its genome through three hierarchically arranged
QS systems, namely Las, Rhl and Pqs [11]. Each system consists of
enzymes involved in autoinducer synthesis and the target
regulator: LasI produces 3-oxo-C12-HSL for activation of LasR
[12], RhlI produces C4-HSL for the activation of RhlR [13,14],
and the biosynthetic enzymes PqsABCDE and PhnAB produce
PQS (2-heptyl-3-hydroxy-4-quinolone) for activation of PqsR [15–
17]. QS systems are also prevalent in many other Gram-negative
bacteria.
QS system is a promising target for anti-virulence therapy
[1,18]. In contrast to classic antibiotics, quorum-quenching
compounds are inhibitors of bacterial virulence, rather than of
bacterial growth [19]. Since the first studies on QS inhibitors, the
halogenated furanones [20], more compounds have been identi-
fied [21,22].
In contrast to Gram-negative bacteria, many Gram-positive
bacteria communicate using modified oligopeptides as signals and
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‘‘two-component’’-type membrane-bound sensor histidine kinases
as receptors. The well-studied QS system in Staphylococcus is the agr
QS system [23]. The excreted signal is a thiolactone- or lactone-
based peptide [24] (AIP, autoinducer peptide) that mediates
communication with other staphylococci in a cell density
dependent way [25,26].
While studying the potential interaction of staphylococci with
Gram-negative bacteria [27,28], we came across another com-
munication system in a Staphylococcus species group, named
‘intermedius group’. This group consists of closely related mainly
coagulase-positive bacterial species including S. delphini, S. interme-
dius, S. lutrae, S. pseudintermedius, and S. schleiferi. They are all
phylogenetically related, are zoonotic pathogens, and only rarely
occur in human infections. We found that these species excrete
two low molecular compounds that inhibit the expression of QS-
controlled toxins and other QS-regulated compounds in Gram-
negative bacteria. The excreted compounds, which we named
yayurea A and B, were isolated from S. delphini and structurally
characterized. Yayurea A and B represent new bacterial products,
and were able to quench the QS regulation in a wide spectrum of
Gram-negative bacteria. Furthermore, growth of yayurea A and B
producing S. delphini is not suppressed by respiratory toxins when
co-cultured with P. aeruginosa. This suggests that the quorum
quenchers have a function in self-protection and competitiveness
in natural environments shared with Gram-negatives. Here we
show an example of inter-phylum interference between Firmicutes
(Gram-positive) and the Gram-negative beta- and gammaproteo-
bacteria.
Results
Staphylococcus delphini suppresses production of QS-
regulated phenotypes in various Gram-negative bacteria
Our aim was to find out if some staphylococcal species are able
to suppress the QS controlled phenotypes in Gram-negative
bacteria. To investigate this, we tested the ability of several
staphylococcal species to inhibit pyocyanin production of P.
aeruginosa in a co-cultivation assay, as pyocyanin production is QS
controlled. We found that S. delphini DSMZ 20771 completely
inhibited pyocyanin production over 24 h co-cultivation with P.
aeruginosa PAO1, while Staphylococcus aureus showed no such
activity (Fig. 1A). This led us to investigate if S. delphini could
also suppress QS-controlled phenotypes in other Gram-negative
bacteria such as the QS-regulated prodigiosin production in
Serratia marcescens [29]; bioluminescence in Vibrio harveyi [7,30]; or
violacein production in Chromobacterium subtsugae, a pathogen of
potato beetles [31]. Indeed, in co-cultivation studies with these
Gram-negative bacteria, S. delphini did also suppress prodigiosin
and violacein production as well as bioluminescence, while S.
aureus did not (Fig. 1BCD). Sterile filtered culture supernatant of a
24 h S. delphini culture had the same QS-inhibiting effect as the
co-culture, indicating that the QS-inhibiting compound(s) were
excreted. The supernatants of S. aureus and S. epidermidis caused no
effect.
Structural analysis of the QS-inhibiting compounds from
S. delphini
The QS inhibitors were isolated from the supernatant of an
overnight culture of S. delphini DSMZ 20771. Further purification
revealed that the supernatant contained two compounds with
different retention times (Rt) in HPLC and distinct UV spectra.
We named the two compounds yayurea A and B.
Yayurea A (indole-ethylurea) was isolated as a brownish solid,
revealed an ion peak at m/z= 161 ([M+H]+) in ESI-MS, and
showed the molecular formula, C10H13N2, in FT-ICR-MS
analysis. The 1H-indole-3-ethylamine moiety was deduced from
GC-EI-MS (Rt = 29.0 min).
1H-NMR spectra showed a charac-
teristic singlet at dH=8.55 ppm. The remaining signals were
assigned to 2-(3-indoyl) ethylamine. The 13C-NMR spectrum and
additional HSQC experiments displayed signals pointing to a
carbonyl group at d=170.4 ppm, five methin groups, and two
methylene groups to reveal a urea moiety. Additionally, 2D NMR
experiments supported the structure of yayurea A as N-[2-(1H-
indole-3-yl) ethyl]-urea (Fig. 2A).
Yayurea B (phenethylurea) was obtained as a colorless solid.
A preliminary molecular formula, C8H10N, was deduced from
the FT-ICR-MS spectrum which showed an ion at m/z= 121
([M+H]+). GC-EI-MS provided a signal at Rt = 15.0 min
pointing to 2-phenethylamine. The 1H-NMR again showed a
set of aromatic protons and a singlet at dH= 8.54 ppm, while
the 13C-NMR displayed a signal at dH= 170.4 ppm (C=O) and
five aromatic and 4 aliphatic protons. In summary, the
structure of N-(2-phenethyl)-urea was assigned for yayurea B
(Fig. 2B). UV-Absorption maxima emphasized the phenyl-
(l=260 nm) and indole chromophores (l=225 nm and
l=280 nm respectively) of the yayureas. Comprehensive
physicochemical characteristics and mass spectra of yayurea A
and B are shown (Table 1 and Figure S1). In the meantime,
yayurea A and B could also be chemically synthesized and their
identity confirmed by mass spectral and NMR analyses (Wo¨lfle
et al. manuscript in preparation). Both the synthesized and the
natural compounds revealed the same chemical properties and
the same QS-quenching activity in Gram-negative bacteria
(data not shown).
Suppression of QS-regulated respiratory toxins protects
S. delphini from killing by Pseudomonas aeruginosa
P. aeruginosa produces various QS-controlled respiratory toxins such
as pyocyanin and hydrogen cyanide [32,33], which kill S. aureus [27]. If
yayurea A and B repress the production of QS-regulated pyocyanin or
hydrogen cyanide, one would expect that S. delphini survives better in a
co-culture with P. aeruginosa than, for example, S. aureus. Indeed, co-
Author Summary
While studying the potential interaction of staphylococci
with Gram-negative bacteria, we came across another
communication system in a Staphylococcus species group,
which consists of closely related coagulase-positive bacte-
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found that these species excrete two small compounds
that inhibit both the expression of QS-controlled toxins
and other QS-regulated compounds as well as growth in
Gram-negative bacteria. The excreted compounds, which
we named yayurea A and B, were isolated from S. delphini
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rial products, which quench the QS regulation in a wide
spectrum of Gram-negative bacteria by stimulating the
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growth of yayurea A and B producing S. delphini is not
suppressed by respiratory toxins when co-cultured with P.
aeruginosa. This suggests that the quorum quenchers have
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natural environments shared with Gram-negatives. Here
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between firmicutes (Gram-positive) and beta-/gammapro-
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New Quorum Quenching Molecules from Staphylococci
PLOS Pathogens | www.plospathogens.org 2 September 2013 | Volume 9 | Issue 9 | e1003654
cultivation studies with S. aureus (non-producer) or S. delphini with P.
aeruginosa SH1 revealed that the viability (CFU) of S. aureus significantly
decreased in the stationary growth phase, most likely due to the
respiratory toxins produced by P. aeruginosa (Fig. 3A), while that of S.
delphini was uninfluenced (Fig. 3B). The addition of yayurea A and B to
the mixed S. aureus and P. aeruginosa culture protected S. aureus from
Figure 1. Quenching of QS-regulated pigments and bioluminescence by S. delphini. P. aeruginosa (A), S. marcescens (B), V. harveyi (C) and
C. subtsugae (D) were each co-cultivated with S. aureus (1) or S. delphini (2) for 24 h. Pyocyanin, which is excreted by P. aeruginosa, was determined in
the supernatant at its absorption maximum A520 nm. Prodigiosin, which is cell wall bound in S. marcescens, was ethanol-extracted from the cell pellet
and determined at its absorption maximum A534 nm. Bioluminescence of V. harveyi was intensified by aeration before measuring in a bioluminescence
reader. Violacein from C. subtsugae was quantitatively extracted with butanol and determined at its absorption maximum A585 nm.
doi:10.1371/journal.ppat.1003654.g001
Figure 2. RP-HPLC profile, UV-spectrum and structures of the two QS-inhibitors purified from S. delphini. (A) QS-inhibitor, N-[2-(1H-
indol-3-yl)ethyl]-urea (yayurea A). (B) QS-inhibitor, N-(2-phenethyl)-urea (yayurea B). RP-HPLC was carried out on an Agilent 1200 and Waters xBridge
C18, 5 mm, 4.66150 mm column; compounds were eluted with a 15 min linear gradient of 0.1% phosphoric acid to acetonitrile at a flow rate of
1.5 ml/min.
doi:10.1371/journal.ppat.1003654.g002
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killing in the stationary phase (Fig. 3A). Furthermore, the CFU of P.
aeruginosa SH1 was unaffected while co-cultured with S. delphini or S.
aureus, indicating that none of the two staphylococcal species was able to
kill P. aeruginosa. Co-cultivation of P. aeruginosa with S. aureus in the
presence of yayureas (100 mg/ml yayurea A and 900 mg/ml yayurea B)
had also no effect on viability of P. aeruginosa (Fig. 3C). Other tested
Pseudomonas strains PAO1 and DSMZ 50071 showed similar results
(data not shown). All in all, these results showed that production of
yayurea A and B enables staphylococci to coexist with Gram-negative
bacteria in a mixed community.
Table 1. Physical data for yayurea A and B.
N-[2-(1H-indol-3-yl)ethyl]-urea (yayurea A) N-(2-phenethyl)-urea (yayurea B)
Formula C11H13O1N3 (203.24 g/mol) C9H11O1N2 (163.20 g/mol)
Melting point 240.8uC 214.9uC
Rf-values 0.10 (CHCl3/MeOH 9:1) 0.63 (MeOH/H2O 7:3) 0.28 (CHCl3/MeOH 9:1) 0.94 (MeOH/H2O 7:3)
1H NMR (600 MHz, MeOH-d4) d 3.11 (t, J = 7.0, 7.4 Hz, 2H), 3.22
(t, J = 7.1, 7.3 Hz, 2H), 7.04 (dd, J = 7.4, 7.5 Hz, 1H), 7.13
(dd, J = 7.7, 7.9 Hz, 1H), 7.17 (s, 1H), 7.37 (d, J = 8.2 Hz, 1H),
7.57 (d, J = 7.9 Hz, 1H), 8.55 (s, 1H).
(600 MHz, MeOH-d4) d 2.95 (t, J = 7.4, 8.1 Hz, 2H), 3.16 (t, J = 7.4,
8.1 Hz, 2H), 7.28 (m, 3H), 7.35 (m, 2H), 8.54 (s, 1H).
13C NMR (150 MHz, MeOH-d4) d 24.9, 41.5, 110.6, 112.7, 119.0, 120.2,
122.9, 124.4, 128.4, 138.5, 170.5.
(150 MHz, MeOH-d4) d 34.9, 42.1, 128.4, 129.9, 130.2, 138.1, 170.2.
MS (ESI) (Positive ions) m/z (%) [M+2H-CONH2]+ 161.11. (Positive ions) m/z (%) [M+2H-CONH2]+ 122.10.
doi:10.1371/journal.ppat.1003654.t001
Figure 3. Survival of staphylococcal strains in mixed culture with P. aeruginosa. (A) CFU of S. aureus alone (SA) and in co-culture with P.
aeruginosa (SA+PA). For the protection test, yayurea A (100 mg/ml) and B (900 mg/ml) were added to the mixture of S. aureus and P. aeruginosa
(SA+PA+yayurea A/B). (B) CFU of S. delphini alone (SD) and in co-culture with P. aeruginosa (SD+PA). (C) CFU of P. aeruginosa SH1 co-cultured with S.
aureus (PA+SA), yayureas (PA+SA+yayurea A/B) or S. delphini (PA+SD). Values represent the means of three independent experiments. Bars indicate
mean standard deviation, SD.
doi:10.1371/journal.ppat.1003654.g003
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Yayurea A and B are mainly produced in stationary
growth phase of S. delphini
We followed the production of yayurea A and B over 24 h in
the supernatant S. delphini grown in TSB. The amount of produced
yayurea A and B was determined by HPLC-analysis; peak
integration was correlated with standard yayurea A and B. The
production of both compounds started at the transition of
exponential to stationary growth phase (after approximately 4 h)
and increased rapidly for the next 5 h; after 24 h little more was
produced (Fig. 4). The production kinetics is reminiscent of a QS
controlled expression. Both compounds were produced in
amazingly high concentrations: yayurea A reached concentration
of 120 mg/ml and yayurea B even 900 mg/ml. This high
concentration is entirely sufficient to suppress QS-systems in
Gram-negative bacteria as can be seen below.
Yayurea A is more active than yayurea B in inhibiting
various QS-controlled traits in Gram-negative bacteria
Purified yayurea A and B inhibited QS-regulated factors in
Gram-negative bacteria in a dose-dependent manner. We tested
prodigiosin production in S. marcescens, bioluminescence in V.
harveyi, and pyocyanin production in P. aeruginosa (Fig. 5 and 6).
Yayurea A and B inhibited production of prodigiosin in S.
marcescens in a dose-dependent way. Inhibition already started at
low concentrations (15 mg/ml) and increased with increasing
concentrations of yayurea A or B. At 250 mg/ml, prodigiosin
production was inhibited at 60% (yayurea A) and 40% (yayurea
B). At a concentration of 1000 mg/ml, prodigiosin production was
completely inhibited by yayurea A, and to approximately 70% by
yayurea B (Fig. 5A). At 500 mg/ml, bioluminescence of V. harveyi
was inhibited by yayurea A and B by 99% and 76% respectively
(Fig. 5B). We also investigated whether yayurea A and B inhibited
biofilm formation in P. aeruginosa and S. aureus. Again yayurea A
quite efficiently inhibited biofilm formation in P. aeruginosa, while
yayurea B was less effective (Fig. 5C). In contrast to gallidermin, a
good biofilm inhibitor in staphylococci [34], both yayureas showed
no biofilm-inhibiting effect with S. aureus (Fig. 5D).
We noticed that high dose of yayurea A and B (especially
yayurea A) inhibit the growth of Gram-negative bacteria. We used
P. aeruginosa as an example to verify the effect of growth and QS
inhibition by yayurea A and B, and used the antibiotic tetracycline
and the well-known QS-inhibitor furanone [35] as controls (Fig. 6).
For QS inhibition, around 50% of the yayurea A and B
concentration was necessary compared to that needed for growth
inhibition (Fig. 6 A, B). Furanone revealed a similar correlation of
growth and QS inhibition; the concentration (31 mg/ml) that
inhibited 40% of growth inhibited 80% of QS (Fig. 6C). In
contrast to yayurea and furanone, tetracycline inhibited growth
and QS almost linearly (Fig. 6D). Besides P. aeruginosa, yayureas
affect also growth of S. marcescens, V. harveyi, and V. cholerae (Figure
S2); however, growth of E. coli was not affected. All staphylococcal
species tested, such as S. aureus, S. carnosus, S. delphini or S. schleiferi,
are resistant to yayurea A and B, independently whether they are
producing these compounds or not.
Yayurea A and B are perceived by the AHL-receptor LuxN
of Vibrio harveyi
To gain insight into the molecular mechanism behind why
yayurea A and B cause a decrease in bioluminescence of V.
harveyi, we performed in vitro phosphorylation assays of the
corresponding signaling proteins. The full-length hybrid kinases
LuxN, LuxQ, CqsS (tagged with 6 histidine residues) were
heterologously expressed in an E. coli strain that lacks the F1/Fo-
ATPase (to prevent ATP degradation during phosphorylation
experiments), and inverted membrane vesicles prepared from this
strain were directly used for the phosphorylation experiments.
Then we tested the effect of yayurea A and B on the LuxN, LuxQ
[in interplay with LuxP (LuxPQ)], and CqsS-mediated time-
dependent phosphorylation of the HPt protein LuxU (Fig. 7A).
Yayurea A and B had no effect on LuxPQ or CqsS-mediated
phosphorylation of LuxU (Fig. 7B). However, they significantly
stimulated the LuxN-mediated phosphorylation of LuxU in
comparison to the control (Fig. 7C, compare lane 2 with lanes
4 and 10). LuxN is the sensor for the AHL autoinducer N-(3-
hydroxybutyryl)-homoserine lactone (HAI-1) (Fig. 7A). It is
known [36] that the presence of HAI-1 inhibits the autophos-
phorylation activity of LuxN, thus decreasing the level of
phospho-LuxU (Fig. 7C, compare lanes 2 and 6).
Yayurea A and B caused the opposite effect, leading to an
increase in the level of phospho-LuxU, which explains the
Figure 4. Quantification of yayurea A and B production in relation to growth. S. delphini was grown in TSB at 37uC. Supernatant was
collected and OD578 was measured hourly for the first 9 h and after 24 h. Amounts of yayurea A and B in supernatants were quantified by triplicate
HPLC measurements. Bars indicate mean standard deviation, SD.
doi:10.1371/journal.ppat.1003654.g004
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Figure 5. Concentration-dependent inhibition of QS-regulated phenotypes in Gram-negative bacteria. (A) Prodigiosin production in S.
marcescens. Cells were grown in MB medium with serial dilutions of yayurea A or B at 28uC. Relative prodigiosin production was calculated as the
ratio between prodigiosin content (absorbance at 534 nm) and cell density (absorbance at 600 nm). (B) Bioluminescence in V. harveyi. Cells were
grown in marine broth with serial dilutions of the compounds at 28uC for 24 h. Relative luminescence units were normalized by the cell density. (C)
Biofilm formation of P. aeruginosa. Cells were grown in LB with serial dilutions of yayurea A or B at 37uC for 24 h. (D) Biofilm formation of S. aureus.
Cells were grown in TSB with serial dilutions of yayurea A, B, or gallidermin (positive control) at 37uC for 24 h. Biofilm cell layer was visualized by
crystal violet staining and measured at 590 nm. Microtiter plates presented are representative of at least three independent sets of experiments. Bars
indicate standard deviation of the mean, SD.
doi:10.1371/journal.ppat.1003654.g005
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decrease in bioluminescence when V. harveyi is exposed to these
compounds. Under our test conditions, autoinducer HAI-1 was
dominant in relation to yayurea A or B (Fig. 7C, compare lane 4
with lanes 8 and 12). Taken together these data show that the
receptor kinase LuxN of V. harveyi specifically recognizes yayurea A
and B. It is still unclear whether yayurea A and B also bind to the
HAI-1 binding site or whether LuxN contains an independent
binding site for these new compounds.
Phylogenetic position of yayurea A and B producing
species in the Staphylococcus taxa
We tested a number of staphylococcal species representatives
(listed in Table 2) by co-cultivation with P. aeruginosa for
suppression of pyocyanin production. Only five species exerted
such an activity: S. delphini, S. intermedius, S. lutrae, S. pseudinterme-
dius, and S. schleiferi, and they all produced yayurea A and B as
determined by HPLC analysis. Based on 16S rRNA- and
multilocus sequence typing (MLST) the species are phylogenetically
related and summarized in the ‘intermedius group’ [37] (Figure
S3). Typically, the species are coagulase positive (with exception
of S. schleiferi subsp. schleiferi), and oxidase negative. Interestingly,
they all colonize various animals, and many represent zoonotic
pathogens [38,39]. None of the other listed staphylococcal species
(even not the next related S. hyicus, S. chromogenes or S. muscae)
inhibited QS-system in Gram-negative bacteria or produced
yayurea A and B.
Discussion
In this study, we found that some staphylococcal species excrete
two novel compounds, yayurea A and B that interfere with the QS
system of diverse Gram-negative bacteria. We tested 24 staphy-
lococcal species with respect to production of yayurea A and B by
co-cultivation with Gram-negative bacteria. The results showed
that only five species (S. delphini [40], S. intermedius [41], S.
pseudintermedius [42], S. lutrae [43], and S. schleiferi [44]) produced
these compounds and were able to inhibit QS-regulated markers
of Gram-negative test bacteria. All five species are naturally
associated with various animals, where they act as zoonotic
pathogens. They are only rarely associated with human infections.
It is remarkable that these species are clustered in various
phylogenetic trees, based on either 16S rRNA [45,46], on
thermonuclease (nuc) sequences [47], on major autolysin (atl)
sequences [48], or on multilocus sequence typing (MLST) [37].
The five species form a phylogenetic cluster, termed ‘‘intermedius
group’’ (Figure S3).
Figure 6. Concentration-dependent inhibition of pyocyanin production and growth of P. aeruginosa. P. aeruginosa PAO1 was grown in
LB at 30uC with serial dilutions of yayurea A (A), yayurea B (B), furanone (C) and tetracycline (D). Relative pyocyanin production was calculated as the
ratio between pyocyanin content and cell density (absorbance at 600 nm). Values represent the means of three independent experiments. Bars
indicate standard deviation of the mean, SD.
doi:10.1371/journal.ppat.1003654.g006
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Figure 7. Yayurea A and B are perceived by V. harveyi LuxN receptor. (A) Schematic representation of the QS phosphorelay in V. harveyi. In
the absence of autoinducers (HAI-1, AI-2 and CAI-1) at low cell density, each of the three receptors, LuxN, LuxQ and CqsS, respectively,
autophosphorylates at a conserved histidine of their histidine kinase domain (HK). The phosphoryl group is first transferred to the receiver domain
(Rec) of the receptor kinase and then to the HPt protein LuxU. LuxP is a periplasmic binding protein. P denotes phosphorylation sites. Upon
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To gain insight into the mode of QS quenching by yayurea A
and B, we performed in vitro phosphorylation assays with the
autoinducer receptors LuxN, LuxQ, CqsS (Fig. 7A). Yayurea A
and B had no effect on LuxPQ or CqsS-mediated phosphorylation
of LuxU. However, they significantly stimulated the LuxN-
mediated phosphorylation of LuxU (Fig. 7B–C), suggesting that
they interact with LuxN and cause LuxU activation. While the
LuxN autoinducer HAI-1, an AHL, inhibits the autophosphory-
lation of LuxN, consequently leading to a decrease in LuxU-
phosphorylation, yayurea A and B caused the opposite effect by
increasing LuxU phosphorylation. Thus, it is suggested that
yayurea A and B keep the V. harveyi in a phenotypic state of low cell
density, although the cells have grown to high density.
When both AI-1 and yayurea A or B were applied, HAI-1
overruled the effect of yayurea A and B in vitro. Bioluminescence of
the wild type strain in vivo significantly decreased after exposure to
yayurea A and B, although the effect of the latter compound was
smaller. Obviously, HAI-1 did not overrule the effect of yayurea A
and B in vivo. This difference can be explained by the fact that
bioluminescence was measured in stationary phase grown cells at a
time when the impact of HAI-1 on QS induction is low [49].
Furthermore, the contribution of the other receptors (LuxQ and
CqsS) and their cognate autoinducers (AI-2 and CAI-1) needs to
be considered in vivo [49]. The ratio of the three receptors and the
impact of their kinase and phosphatase activities on the output of
the phosphorylation cascade is not yet fully understood. This could
be another explanation for the strong effect of the quorum
quenchers in vivo. Membrane-topology analysis predicts that LuxN
is bound to the bacterial inner-membrane by nine transmembrane
(TM) spanning domains [50], and periplasmic loop 3 might be the
HAI-1 binding site [21]. We believe that yayurea A and B interfere
with the AHL quorum sensing response of Gram-negative
bacteria; since the tested bacteria on which the effects were
observed have at least one AHL-based quorum sensing system
(Pseudomonas, Chromobacterium, Vibrio, and Serratia).
Most natural environments harbor a stunningly diverse
collection of microbial species. One example, is the marine
bacterium Halobacillus salinus, which produces N-(29-phenylethyl)-
isobutyramide and 2,3-methyl-N-(29-phenylethyl)-butyramide
[51]. These compounds are unrelated to yayurea A (N-[2-(1H-
indol-3-yl)ethyl]-urea) and B (N-(2-phenethyl)-urea). Within these
communities, bacteria compete with their neighbors for space and
resources [52]. Zoonotic commensals and pathogens, including
yayurea producing staphylococcal species, use animals as a
habitat. Whether these animals are also colonized by Gram-
negative bacteria, other than in the gut, has barely been
investigated. However, one can assume that animals bathe in
puddles, lakes, and rivers, suggesting that their mucus, skin, fur, or
feathers may easily encounter Gram-negative bacteria, being
transient to permanent colonizers. One can also assume, that the
‘intermedius group’ share the habitat animal with Gram-negative
bacteria. S. delphini was isolated from dolphin. Since both V. harveyi
and S. delphini are marine bacteria and animal pathogens, it is
conceivable that both bacteria share the same habitat and
moreover, the same host surface. Our results demonstrated
suppression of the quorum sensing regulated bioluminescence of
V. harveyi during co-culture with S. delphini (Fig. 1), indicating that
yayurea A and B are effective quorum quenchers.
perception of the autoinducers at high cell density, autophosphorylation of the receptors and the subsequent phosphosphrylation cascade is
inhibited. Yayurea A and B stimulated the phosphorylation of the cascade via LuxN. (B) LuxPQ and CqsS mediated phosphorylation of LuxU in the
presence of yayurea A and B. (C) LuxN mediated phosphorylation of LuxU in the presence of yayurea A and B and HAI-1. LuxQ, CqsS, LuxN-bearing
membrane vesicles and LuxU, were incubated with 100 mM [c-32P] ATP. The effect of yayurea A, B and HAI-1 (C) on the initial rate of LuxU
phosphorylation was evaluated. Each reaction was sampled and stopped at two different time points: after 1 and 10 minutes. Final concentrations
were 20 mM for HAI-1, 1.1 mM for yayurea A and 1.3 mM yayurea B, which reflects the in vivo situation. Absence of HAI-1 or yayurea A or B is
indicated by ‘‘2’’ and presence by ‘‘+’’.
doi:10.1371/journal.ppat.1003654.g007
Table 2. Strains tested for Q-quenching activity and yayurea
A and B production.
Strains QS-inhibition
S. aureus RN4220 2
S. aureus SA113 2
S. aureus 8325-4 2
S. aureus RN1 2
S. aureus HG001 2
S. aureus HG002 2
S. aureus HG003 2
S. aureus Newman 2
S. arlettae DSMZ 20672T 2
S. carnosusTM300 DSMZ 20501 2
S. capitis subsp. capitis LK499 ATCC 27840 2
S. caprae DSMZ 20608T 2
S. chromogenes DSMZ 20454T 2
S. cohnii subsp. cohnii DSMZ20260 2
S. condiment DSMZ 11674T 2
S. delphini DSMZ 20771 +++
S. epidermis ATCC14990 2
S. equorum subsp. equorum DSMZ 20674T 2
S. gallinarum DSMZ 20610T 2
S. muscae DSMZ 7068T 2
S. haemolyticus CCM2737 2
S. hominis DSMZ 20328 2
S. hyicus NCTC 10350 2
S. intermedius CCM 5739 +
S. lentus DSMZ 20352T 2
S. lugdunesis ATCC 43809 2
S. lutrae DSMZ10244T +
S. pasteuri ATCC 51129 2
S. pseudintermedius ED99 +++
S. saprophyticus subsp. saprophyticus DSMZ 200229 2
S. schleiferi subsp. coagulans ATCC49545 ++
S. schleiferi subsp. schleiferi DSMZ 4807 +++
S. simulans MK148 ATCC 27848 2
S. warneri DSMZ 20316T 2
S. xylosus DSMZ 20266 2
(+), Species that produce yayurea A and B.
doi:10.1371/journal.ppat.1003654.t002
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The in vitro phosphorylation assay gave first mechanistic insights
on how yayurea A and B affect quorum sensing of V. harveyi. We
detected a significant and specific effect of yayurea A and B on the
AHL-receptor LuxN. The concentrations used for these in vitro
assays might not be physiological, especially when the influence of
both molecules (HAI-1 and yayurea) was studied. Furthermore, it
should be noted that HAI-1 is not constantly produced [49].
Therefore, in the natural habitat there might be times, when
yayurea from S. delphini can fully interact with LuxN from V. harveyi
in the absence of any competition with HAI-1. It therefore makes
sense that the zoonotic staphylococci impair the QS-system of
Gram-negative bacteria for competitive reasons. The growth of
these staphylococci is not impaired by P. aeruginosa because the
excreted yayureas suppress the production of the QS-controlled
toxins and are thereby protected from being killed by the toxins
(Fig. 3). While biofilm formation appears to be modulated by
many regulators and environmental conditions in P. aeruginosa,
pyocyanin and cyanide are controlled by the Las-QS system [53],
implying that yayurea A and B might compete with 3-oxo-C12-
HSL for LasR interaction.
When yayurea A (125 mg/ml) was added, the growth of P.
aeruginosa was not affected (Fig. 6A), but quorum sensing and
biofilm formation (Figs. 6A and 5C) were inhibited by 20%, which
indicates that biofilm inhibition takes place prior to the onset of
growth inhibition. In addition to their quorum quenching activity
in Gram-negative bacteria, yayureas also inhibited their growth at
higher dose (Fig. 2), which is a further advantage in the race for
space and resources. For this advantage the zoonotic staphylococci
are apparently prepared to pay a certain price, namely the
production and excretion of comparatively high amounts of
yayurea A and B. However, the benefit in competitiveness appears
to prevail the cost disadvantages. As QS controls not only
virulence factors but also many metabolic functions important for
fitness, we don’t know whether the inhibition of growth is a
consequence of QS-inhibition or vice versa [54–56]. For some
antibiotics (azithromycin, ceftazidime, and ciprofloxacin), it has
been shown that they decrease the expression of QS-regulated
virulence and many other genes [57].
The yayureas are potential candidates for use as anti-
infectives. The only disadvantage might be the rather high
concentration needed to completely quench QS; on the other
hand, preliminary results suggest that they hardly have
cytotoxic activities.
An interesting question is why just the ‘intermedius group’ is
producing yayureas. The most likely answer is that this group
shares its habitat with Gram-negative bacteria. There must be a
benefit to producing yayurea A and B because they are excreted in
such high amounts certainly costing energy. In addition, the
yayureas show growth inhibition only at quantities that exceed the
physiological concentrations. It is a clever arrangement, that S.
delphini produces just enough yayurea A and B to almost
completely silence the expression of the studied QS-regulated
compounds or biofilm formation in diverse Gram-negative
bacteria. In mixed cultures, the yayurea-producing staphylococci
arrest Gram-negative bacteria in a pheno- and genotypic state of
low cell density, although the cells have grown to high density. The
advantage for the staphylococci is twofold, on one hand, they are
protected from QS-controlled toxins and on the other hand,
yayurea A and B affect stationary growth of particularly those
Gram-negative bacteria with prominent QS-control systems. This
is one of the rare cases of inter-phylum interference between
firmicutes (Gram-positive) and beta-/gammaproteobacteria
(Gram-negative). A schematic presentation of the interference is
shown in Fig. 8.
Materials and Methods
Bacterial strains and growth conditions
Staphylococcus strains were grown in Tryptic Soy Broth (TSB,
Sigma) medium at 37uC, Vibrio cholerae SP27459 (O1 El Tor),
Serratia marcescens, Chromobacterium subtsugae DSMZ 17043 and
Pseudomonas aeruginosa were grown in lysogenic broth (LB) medium,
and Vibrio harveyi DSMZ6904 in marine broth (MB; 5 g peptone,
3 g yeast extract and 75% sea water per liter of deionized water) at
28uC. The Staphylococcus strains tested in this work are listed in
Table 2.
Figure 8. Schematic presentation of the interference between zoonotic staphylococcal species and Gram-negative bacteria. Animal
associated (zoonotic) Staphylococcus species excrete novel quorum-quenching compounds, yayurea A and B, which block quorum sensing system in
various Gram-negative bacteria by activating LuxN phosphorylation and have also growth inhibiting activity. The benefit for the staphylococcal
species is better survival and increased competitiveness in a joint ecosystem.
doi:10.1371/journal.ppat.1003654.g008
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Mixed cultivation of Staphylococcus sp. with P. aeruginosa
In co-culture experiments, we inoculated TSB with S. aureus
(OD578 0.005) and P. aeruginosa SH1 (OD578 0.005). For the
protection test, yayurea A (100 mg/ml), yayurea B (900 mg/ml), or
water (control) were added to the mixed culture of S. aureus and P.
aeruginosa after 3 h incubation. For co-cultivation of S. delphini with
P. aeruginosa, each of the strains was inoculated with OD578 0.001,
because doubling time of S. delphini was shorter than that of S.
aureus. Co-cultures were aerobically grown at 37uC. For CFU
determination, samples were diluted and plated on Chapman agar
(selective medium for staphylococci, while growth of P. aeruginosa is
retarded) and BM agar (1% tryptone, 0.5% yeast extract, 0.5%
NaCl, 0.1% K2HPO4, 0.1% glucose) on which P. aeruginosa grows
better than the staphylococci. Colonies were counted after
incubating for 24 h at 37uC; staphylococcal and pseudomonas
colonies could be easily distinguished by colony shape and
pigmentation.
Purification and structural analysis of the QS-inhibiting
compounds from S. delphini
The QS inhibitors were isolated from aerobically-grown
overnight culture of S. delphini (vigorous shaking at 37uC, 20 h).
Cells were centrifuged and the supernatant was applied to an
Amberilite XAD 16 resin (Rhom& Haas, Germany). The column
was first washed with water, then with 40% and 60% methanol
and finally eluted with solvent A (80% methanol containing 5%
acetic acid). Yayureas were significantly enriched in the last
fraction. In the second purification step, the eluate was evaporated
in vacuo, suspended in water, and further separated on an
Amberilite IRC 50 cation exchange resin (Serva, Heidelberg,
Germany) after the pH was adjusted to 7.0 with 1 M NaOH. The
column was washed with water, then 70% ethanol and eluted with
solvent A. The eluate was concentrated in vacuo, diluted, and
adjusted to a final concentration of 50 mM sodium phosphate
buffer with a pH of 4.2. In the third purification step, the eluate
was separated on a SP Sepharose cation exchange column (GE
Healthcare, Germany) with a linear 1 M NaCl gradient in 50 mM
sodium phosphate buffer on a A¨kta FPLC (GE Healthcare,
Germany). The two active compounds were eluted separately at
120 mM and 280 mM NaCl concentration respectively. The final
purification and desalting of each peak was carried out by reversed
phase preparative HPLC (RP-HPLC) (Bischoff, Leonberg, Ger-
many) on a nucleosil 100 C-18, 86250 mm column (Machery
Nagel, Du¨ren, Germany) with a linear water acetonitrile
(containing 0.1% TFA) gradient of 0% to 60% in 25 min. Purified
compounds were lyophilized and stored at 220uC. Qualitative
analysis was carried out on an Agilent 1200 HPLC system (Agilent
technologies, Waldbronn, Germany) and a RP-HPLC Waters
xBridge C18, 5 mm, 4.66150 mm column. Compounds were
eluted with a 15 min linear gradient of 0.1% phosphoric acid to
acetonitrile at a flow rate of 1.5 ml/min. For structure elucidation,
mass spectrometry was carried out on GC-MS and FT-ICR MS
(Bruker, ApexII). NMR spectra were measured in d4-methanol
and recorded on a Bruker AMX600 spectrometer (600 MHz for
1H, 150 MHz for 13C), solvent was used as internal standard (dH/C
3.31/49.15 for MeOH-d4).
Assessing QS-regulated compounds in S. marcescens, P.
aeruginosa, C. subtsugae, and bioluminescence in V.
harveyi in co-cultivation with Staphylococcus sp.
Overnight cultures of S. aureus and S. delphini cells were diluted in
LB medium containing 0.3% glucose to an OD578 value of 1.0 (we
also tried 0.1, 0.5, but OD 1.0 results were most pronounced),
incubated for 4 h at 37uC, then co-cultivated at 30uC with S.
marcescens or P. aeruginosa; each strain was inoculated with a starting
OD600 of 0.01. After 24 h of cultivation, prodigiosin of S. marcescens
was extracted from the cell pellets by ethanol acidified with 4% of
1 M hydrochloric acid and then quantified by A534 nm determi-
nation. Pyocyanin in the supernatant was determined by its
absorption maximum at 520 nm [58]. For bioluminescence tests,
overnight-cultured V. harveyi was diluted to an OD578 of 1.0 and co-
cultivated with an equal amount of S. aureus or S. delphini cells in LB-
MB (LB medium containing 0.1% glucose mixed with equal
volumes of MB) for 18 h. Overnight cultures of S. aureus and
S. delphini cells were diluted to an OD578 of 0.1, incubated for 4 h at
37uC, then co-cultivated at 30uC with C. subtsugae, which was diluted
to a final OD600 value of 2; this highODwas necessary to pronounce
violacein production, whose expression is dependent on AHL at
higher cell density. After 24 h of incubation, cell pellets were
collected and resuspended in water. Cells were lysed by 10% sodium
dodecyl sulfate and incubated for 5 min at room temperature.
Violacein was quantitatively extracted from the cell by adding water-
saturated butanol. The butanol phase containing the violacein was
collected and determined at its absorption maximum at 585 nm.
Production of yayurea A and B in S. delphini and their
effect on bacterial growth
S. delphini was inoculated to a starting OD578 of 0.1 and
incubated at 37uC. During the 24 h incubation, cell density was
followed by OD578 and the active compounds in the supernatants
were determined by RP-HPLC and phosphoric acid – acetonitrile
gradient as described above. The Gram-negative representatives,
E. coli, P. aeruginosa, S. marcescens, V. cholerae and V. harveyi were
inoculated to OD600 of 0.1 and grown in LB for 2 h. After that
time, 1 mg/ml yayurea A or B (as solution in H2O) or an equal
volume of water as negative control was added. Cells were either
incubated at 37uC (S. aureus or S. delphini) or 30uC (E. coli, S.
marcescens, V. harveyi, V. cholerae and P. aeruginosa). Cell density was
followed for 24 h.
Activity assays for QS-regulated compounds,
bioluminescence, and biofilm formation in Gram-
negative bacteria
Pyocyanin production. An overnight culture of P. aeruginosa
PAO1 was diluted with LB medium to an OD600 of 0.1. The (Z-)-4-
bromo-5-(bromomethylene)-2(5H)-furanone (Sigma), yayureas and
tetracycline were dissolved in 10% DMSO. 190 ml diluted PAO1
was cultured in 96-well plates with 10 ml different concentrations of
pure yayurea A, B, furanone, or 10% DMSO (negative control) at
30uC. After 24 h of incubation, cell density was measured at 600 nm
and pyocyanin was isolated as described previously [58]. Tomeasure
pyocyanin production, the supernatants were subjected to HPLC
separation on a Nucleosil 100, C-18 column and a 0–100% Water-
ACN Gradient (water containing 0.1% phosphoric acid) in 15 min
at a flow rate of 1.5 ml/min. The content of pyocyanin was
determined at its absorption maximum at 520 nm [58]. The relative
pyocyanin production was calculated as the ratio of the amount of
pyocyanin content from the HPLC measurements to cell density.
Prodigiosin production. S. marcescens cells were inoculated
from an overnight culture to a starting OD600 of 0.1. Then 100 ml of
the diluted culture was mixed with 100 ml of different amounts of the
purified compounds or water in wells of 96-well microtiter plates and
incubated for 24 h at 28uC. Cell density was measured at 600 nm.
Prodigiosin was extracted as described above and the relative
prodigiosin production was calculated as the ratio between the
amount of prodigiosin at its absorptionmaximum at 534 nm and cell
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density values at 600 nm. The prodigiosin suppressing effect of
yayurea A and B was determined (H2O was used as control).
Biofilm formation assay. Biofilm formation assays were
performed as described previously [34]. A full-grown culture of P.
aeruginosa PAO1 or S. aureus was diluted with LB medium containing
0.3% (w/v) glucose to an OD600 of 0.1. 100 ml of the dilution was
mixed with 100 ml of the yayurea solutions with the indicated
concentrations, and incubated in 96-wellplates at 37uC for 24 h. To
determine the biofilm formation, planktonic cells were discarded
and the plates gently washed with PBS and air-dried for 30 min.
The wells were stained with 200 ml of a 0.1% crystal violet solution
at room temperature for 30 min. The stained biofilm was rinsed
with distilled water followed by the addition of 200 ml DMSO.
Absorbance of crystal violet as indicator for biofilm-forming
bacteria was measured at 590 nm. The effects of the compounds
were evaluated for which the sample with water was set to 100%.
Bioluminescence. An overnight culture of V. harveyi was
diluted to an OD600 of 0.1 and grown with yayurea A, B, or water
for 24 h at 28uC. Bioluminescence was determined in a Tecan
infinite M200 plate reader (Tecan, Groedig, Austria). Relative
luminescence was normalized by the OD600 values. The effects of
the compounds were calculated by the relative luminescence, for
which the sample with water was set to 100%.
Investigation of the QS-target(s) of yayureas in vitro
Production of QS-receptors and QS-molecules. Inverted
membrane vesicles were prepared using E. coli strainTKR2000
expressing plasmids pNKN, pNKQ, and pNKS encoding wild type
LuxN, LuxQ, andCqsS (each with a C-terminal His-tag), respectively.
Invertedmembrane vesicles were prepared as described by [36]. LuxP
was produced in, and purified from, E. coliMDAI-2 transformed with
the plasmid pGEX_LuxP as described before [59]. LuxU was
produced and purified as described before, using E. coli JM109
transformed with plasmid pQE30LuxU-6His [36]. Synthetic auto-
inducer, HAI-1, (from the University of Nottingham) was dissolved in
a minimal volume of acetonitrile [10% (v/v)], diluted with water to a
concentration of 100 mM and stored at 220uC.
Phosphorylation assays. Each QS-receptor kinase was
tested as full-length membrane integrated proteins in inverted
membrane vesicles. The buffer used for phosphorylation reactions
was as follows: 50 mM Tris/HCl pH 8.0, 10% (v/v) glycerol,
500 mM KCl, 2 mM DTT. Each phosphorylation reaction
contained equimoloar receptor concentrations [the total protein
concentration were accordingly adapted: 3.2 mg/ml (LuxN),
5.5 mg/ml (LuxQ), and 5.2 mg/ml (CqsS) membrane proteins],
and purified LuxU at 0.1 mg/ml. For phosphorylation of LuxQ,
LuxP was added at a concentration of 0.4 mg/ml. LuxP
integration into LuxQ-bearing membrane vesicles was triggered
by several cycles of thawing and freezing. When indicated, yayurea
A or B were added to the reaction mix at a final concentration of
220 mg/ml, and HAI-1 at 20 mM. The reaction was started by
adding radio labeled Mg2+-ATP, typically 100 mM [c-32P]ATP
(specific radioactivity of 0.94 Ci/mmol; Perkin Elmer) and
110 mM MgCl2. The reaction was stopped after 1 and 10 minutes
by adding SDS Laemmli-loading buffer followed by separation of
the proteins on SDS-polyacrylamide gels. Gels were dried at 80uC
on filter paper, exposed to a phosphoscreen for at least 24 h, and
subsequently scanned using a PhosphorImager SI (GE Health-
care). The gels presented are representative of at least three
independent sets of experiments.
Supporting Information
Figure S1 Mass spectra of Yayurea A and B. Mass
spectrometry was carried out on GC-MS and FT-ICR MS
(Bruker, ApexII).
(TIF)
Figure S2 Influence of yayurea A and B on growth.
Growth curve of S. marcescens, P. aeruginosa, V. harveyi and V. cholerae
in BM with 1000 mg/ml yayurea A or B or equal volume of water.
Arrow indicates time point (after 2 h) of the addition of
compounds to the growing culture. All the measurements were
made in triplicate. Bars indicate standard deviation, SD.
(TIF)
Figure S3 Phylogenetic tree among Staphylococcus spe-
cies. The tree is based on 16S rRNA relationships according to
[45]. The phylogenetic position of the ‘intermedius group’ composed
of S. intermedius, S. pseudintermedius, and S. delphini is marked in bold.
Based on a combinatin of 16S rRNA and multilocus data, the group
was recently complemented by the next related species S. lutrae, S.
schleiferi subsp. schleiferi and S. schleiferi subsp. coagulans [37]. All
members of this group produce yayurea A and B.
(TIF)
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[Abstract] The knowledge that many pathogens rely on cell-to-cell communication mechanisms known as 11 
quorum sensing, opens a new disease control strategy: quorum quenching. Here we present a purification 12 
protocol for molecules excreted by a group of Gram-positive zoonotic pathogen bacteria, the 13 
‘Staphylococcus intermedius group’, that suppress the quorum sensing signaling and inhibit the growth of a 14 
broad spectrum of Gram-negative beta- and gamma-proteobacteria. These compounds were isolated 15 
from Staphylococcus delphini. They represent a new class of quorum quenchers with the chemical 16 
formula N-[2-(1H-indol-3-yl)ethyl]-urea and N-(2-phenethyl)-urea, which we named yayurea A and B, 17 
respectively. These substances can be isolated and purified from the culture supernatant using this 18 
upscalable purification method. 19 
 20 
Materials and Reagents 21 
 22 
1. Staphylococcus delphini DSMZ20771 strain (DSMZ: Deutsche Sammlung von Mikroorganismen und 23 
Zellkulturen, DSM number: 20071 ) 24 
2. Tryptic Soy Broth (TSB) (Sigma-Aldrich, catalog number: T8907)  25 
3. Amberilite XAD-16 resin (Sigma-Aldrich, catalog number: 1-0379)  26 
4. Methanol  27 
5. Acetic acid (Merck KGaA) 28 
6. Amberilite IRC 50 cation exchange resin (SERVA Electrophoresis, catalog number: 40501) 29 
7. Sodium hydroxide  30 
8. Ethanol  31 
9. 50 mM  and 1M Sodium phosphate buffer  32 
10. SP Sepharose cation exchange column (GE Healthcare, catalog number:17-5161-01) 33 
11. Sodium chloride 34 
12. Trifluoroacetic acid (TFA) (Sigma-Aldrich, catalog number: T6508) 35 
13. Phosphoric acid for HPLC (Sigma-Aldrich, catalog number: 79606) 36 
14. Acetonitrile for HPLC (Mallinckrodt Baker, catalog number: 9012) 37 
 38 
Equipment 39 
 40 
1. 37 °C shaking incubator (INFORS) 41 
 2 
2. Centrifuge (Eppendorf) 42 
3. Rotary evaporator (BÜCHI Labortechnik AG) 43 
4. Äkta FPLC equipped with P-900, UV-900, PH/C-900 (GE Healthcare) 44 
5. Preparative HPLC System equipped with Bischoff HPLC compact pump QC-P 2250 and 45 
Multiwavelength detector QC-1157 (Bischoff) 46 
6. Nucleosil 100 C-18 (8 × 250 mm column) (MACHEREY-NAGEL, catalog number:715332.80) 47 
7. Agilent 1200 series HPLC system (Agilent)  48 
8. Waters XBridge C18 (5 mm, 4.6 × 150 mm column) (Waters, part number:186003116) 49 
 50 
Procedure 51 
 52 
1. S. delphini is cultivated in 100 ml TSB at 37°C on a shaking incubator at 150 rpm for 20 h. 53 
2. Cells are centrifuged at 5000 rpm (4500 x g) at 4oC for 10 min and the supernatant is applied on to a 54 
column filled with 10 ml Amberilite XAD-16 resin. 55 
3. The column is first washed with 5 bed volumes each of milliQ water, then with 40% and 60% 56 
methanol and finally eluted with 80% methanol containing 5% acetic acid at a flow rate of 10 bed 57 
volumes per hour. 58 
4. The eluate is evaporated using a rotary evaporator until all methanol is removed. 59 
5. The eluate is resuspended with 50ml water and the pH adjusted to 7.0 with 1 M NaOH. It is then 60 
applied on to a column filled with 10ml Amberilite IRC-50 cation exchange resin.  61 
6. The column is washed first with water, then with 70% Ethanol and eluted with 80% Ethanol acidified 62 
with 5% acetic acid each with 5 bed volumes at a flow rate of 10 bed volumes per hour. 63 
7. The eluate is concentrated using a rotary evaporator until all methanol is removed. 64 
8. The eluate is diluted with water and adjusted to a final concentration of 50 mM sodium phosphate 65 
using 1 M sodium phosphate buffer and pH is lowered to 4.2 using 85% phosphoric acid. 66 
9. In the third purification step, the eluate is separated on a 5 ml SP Sepharose cation exchange 67 
column with a linear 0 to 1 M NaCl gradient in 50 mM sodium phosphate buffer on an Äkta purifier 68 
FPLC at a flow rate of 3 ml/min. 69 
10. The final purification and desalting of each peak is carried out by reversed phase preparative HPLC 70 
(RP-PHPLC) on a nucleosil 100 C-18, 8 × 250 mm column with a linear water acetonitrile (containing 71 
0.1% TFA) gradient of 0% to 60% in 25 min. 72 
11. Purified compounds are lyophilized and stored at −20 °C. 73 
12. Qualitative analysis is carried out on an Agilent 1200 HPLC system and a RP-HPLC Waters xBridge 74 
C18, 5 mm, 4.6 × 150 mm column. Compounds are eluted with a 15 min linear gradient of aquaeus 75 
phosphoric acid (0.1% vol/vol) to acetonitrile at a flow rate of 1.5 ml/min and detected at 210 nm. 76 
 77 
 3 
 78 
Figure 1. RP-HPLC profile, UV-spectrum and structures of the two QS-inhibitors purified from 79 
S. delphini. A. QS-inhibitor, N-[2-(1H-indol-3-yl)ethyl]-urea (yayurea A). B. QS-inhibitor, N-(2-80 
phenethyl)-urea (yayurea B). RP-HPLC is carried out on an Agilent 1200 and Waters xBridge C18, 5 81 
mm, 4.6 x 150 mm column; compounds are eluted with a 15 min linear gradient of 0.1% phosphoric 82 
acid to acetonitrile at a flow rate of 1.5 ml/min.  83 
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Abstract32
Bacterial adhesion on implants is a first step in the development of chronic foreign 33
body associated infections. Finding strategies to minimize bacterial adhesion may contribute 34
to minimize such infections. It is known that surfaces with oligo-ethylene-glycol (EG3OMe) 35
or poly-ethylene-glycol (PEG2k) terminations decrease unspecific protein adsorption and 36
bacterial adhesion. However, little is known about the influence of serum and its components 37
on bacterial adhesion. We therefore prepared two coatings on gold surface with HS-38
(CH2)11EG3OMe (EG3OMe) and PEG2k-thiol and studied the role of bovine serum albumin 39
(BSA), γ-globulins, and serum on Staphylococcus aureus adhesion. While BSA and lysozyme 40
showed no adherence even when applied at very high concentrations (100 mg/ml), γ-globulins 41
adsorbed already from 10 mg/ml on. The adsorption of γ-globulins was, however, 42
significantly decreased when it was mixed with BSA in a ratio of 3:1, as it is in the serum. 43
Pretreatment of EG3OMe and PEG2k coatings with γ-globulins or serum strongly promoted 44
adherence of S. aureus when resuspended in buffer, suggesting that γ-globulins play a pivotal 45
role in promoting S. aureus adhesion by its IgG binding proteins; the finding that a spa-46
deletion mutant, lacking the IgG binding protein A, showed decreased adherence corroborated 47
this. Similarly, when S. aureus was pretreated with serum or γ-globulins its adherence was 48
also significantly decreased. Our findings show that particularly γ-globulins bind to the coated 49
surfaces thus mediating adherence of S. aureus via its protein A. As pretreatment of S. aureus50
with serum or γ-globulins significantly decreased adherence, treatment of patients with γ-51
globulins before implant surgery might lower the risk of implant-associated infections.52
53
Keywords: Albumin, bovine serum, γ-globulins, oligo (ethylene glycol) (EG3OMe) thiol 54
surface coating, poly(ethylene glycol) (PEG2k) thiol surface coating, Staphylococcus aureus 55
adhesion56
57
58
Introduction59
      Infections related to indwelling medical devices are one of the major causes of persistent 60
clinical infections (Costerton et al., 1999). These infections are frequently complicated by 61
biofilm formation, during which the pathogenic microorganisms adhere to the surfaces of the 62
medical devices and develop a thick, multilayered slimy matrix (Cramton and Götz, 2004; 63
Cramton et al., 1999; Gross et al., 2001; Kropec et al., 2005; Rohde et al., 2005). Once the 64
biofilm is formed, the embedded microorganisms are highly resistant to multiple antibiotics 65
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and host immune defense (Gray et al., 1984; Stewart and Costerton, 2001). Often, the only 66
way to eradicate such infections is to surgically remove the infected indwelling device. The 67
nonspecific and reversible adhesion of microorganisms to the surfaces of the biomaterials is 68
the critical step in biofilm infections. Pathogenic microorganisms have employed a variety of 69
factors for successful adhesion. As the most common biofilm associated microorganisms, 70
Staphylococcus epidermidis and Staphylococcus aureus exploit major autolysin (Heilmann et 71
al., 1997), surface proteins SasG, SasC (Roche et al., 2003; Schroeder et al., 2009) as well as 72
teichoic acids (Gross et al., 2001) to initiate adhesion. Immunoglobulin-, fibrinogen-, 73
fibronectin-, or collagen- binding proteins promote the adhesion of S. aureus to a surface if 74
the surface is coated with the corresponding matrix proteins (Götz and Peters, 2000). 75
       Preventing the initial adhesion of microorganisms to the surfaces of biomaterials is 76
thought to be an efficient way to treat implant-associated infections. Apart from attempts to77
target bacterial adhesion factors by selected antibiotics (Saising et al., 2012), much attention 78
has been paid in recent years to engineering biomaterial surfaces to become more resistant to 79
bacterial adhesion. Self-assembled monolayer (SAMs) based surface coatings with oligo-80
ethylene-glycol (OEG) or poly-ethylene-glycol (PEG) terminations render surfaces resistant 81
against non-specific protein adsorption and bacterial adhesion, which appears to be a 82
promising approach (Pale-Grosdemange et al., 1991; Prime and Whitesides, 1993). The 83
mechanisms for the protein resistance property of PEG coated surfaces are proposed to be free 84
energies of steric repulsion, hydrophobic interactions and van-der-Waals interactions (Jeon 85
and Andrade, 1991). Both grafting density and chain length are critical parameters for the 86
efficiency of PEG in preventing protein adsorption and bacterial adhesion (Holmberg et al., 87
1993). Due to the short chains and highly ordered conformation, the mechanisms of the 88
protein resistant property of OEG coatings are different in many parameters such as the 89
surface coverage, the conformation and the types of end groups (Love et al., 2005; Schreiber, 90
2004; Ulman, 1996).91
      As the implant-associated infections often occur in complex biological systems, it is 92
important to assess the influence of environmental factors on the interaction between bacteria 93
and the biomaterial's interfaces. Blood plasma is one of the most relevant environmental 94
factors for medical device related infections. Under clinical conditions, significant protein 95
adsorption from blood plasma has been observed for various modified interfaces (Benesch et 96
al., 2001; Olsson et al., 1992). While previous studies focus either on the resistance against 97
bacterial adhesion in single protein solution (Cheng et al., 2007) or on plasma protein 98
adsorption without testing bacterial adhesion (Zhang et al., 2008), an advanced understanding 99
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of how plasma proteins affect the bacterial adhesion to the interfaces is largely missing (Deng 100
et al., 1996; Katsikogianni and Missirlis, 2004). 101
        In the current work, we prepared EG3OMe (HS-(CH2)11EG3OMe, one kind of OEG 102
coating) and PEG2k (one kind of PEG coating) coated surfaces that had good 103
physicochemical properties in preventing protein adsorption and S. aureus adhesion. We then 104
compared the protein adsorption behavior of bovine serum albumin (BSA), γ-globulins and 105
whole bovine serum at their physiological concentrations. Further, the effects of BSA, γ-106
globulins and serum on initial adhesion of S. aureus to the EG3OMe and PEG2k coated 107
surfaces were investigated. Our results showed that albumin, γ-globulins and serum had 108
distinct protein adsorption behaviors and consequently different effects on bacterial adhesion. 109
While γ-globulins readily adhered to the coated surfaces, albumin did not adhere and even 110
suppressed γ-globulin adherence in mixed solution. Protein A played a crucial role in 111
adherence when the coatings were pretreated with serum or γ-globulins. However, when S. 112
aureus cells were pretreated with serum or γ-globulins to saturate protein A adherence was 113
significantly decreased.114
115
Materials and Methods116
117
Preparation of OEG and PEG coatings on gold (Au) surfaces118
Silicon wafers (Si<111>) coated with a 5 nm Ti layer and a 200 nm evaporated Au layer were 119
used as substrates for coating. The wafers were cleaned by rinsing in Milli-Q water (18.2 MΩ 120
cm, Millipore) and ethanol (99.9%, Riedel de Haen), dried in an argon stream, treated with 121
ozone producing UV-light for 20 min and rinsed with Milli-Q water again. The coating 122
procedure was performed directly after the cleaning. For the OEG coating preparation, a 500 123
µM solution of HS-(CH2)11EG3OMe (EG3OMe) or EG6OMe in ethanol was used with an 124
immersion time of 24 h (Skoda et al., 2007; Zorn et al., 2011). For the PEG coatings, a 50 µM 125
solution of PEG2k or PEG5K in N, N-Dimethylformamide (DMF) was used with an 126
immersion time of 48 h (Schilp et al., 2009). After removal of the surfaces from the thiol 127
stock solutions, the coated surfaces were rinsed with pure ethanol and dried with a nitrogen 128
stream (Skoda et al., 2007; Zorn et al., 2010). The coated samples were stored in the dark in a 129
nitrogen environment. The structures of EG3OMe and PEG2k are shown in Fig. 2. 130
131
Protein adsorption experiment132
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The EG3OMe and PEG2k coated surfaces were rinsed briefly in Milli-Q water and then dried 133
in an Argon stream. Directly after this procedure the surfaces were incubated in a protein 134
solution for 15 min, washed briefly with Milli-Q water and dried with an Argon stream. 135
Proteins tested were lysozyme, fibrinogen, bovine serum albumin (BSA) and bovine γ-136
globulins (Sigma-Aldrich, Germany). In the first experiment, BSA, lysozyme and fibrinogen 137
were tested at a concentration of 1 mg/ml. In the second experiment, individual proteins of 138
different concentrations (1, 10, 20, 50, 100 mg/ml) were tested. Lastly, protein adsorption of a 139
mixture of BSA (end concentration 30 mg/ml) and γ-globulins (end concentration 10 mg/ml) 140
in a ratio of 3:1 and the whole bovine serum were studied.141
142
Protein desorption and analysis by SDS-PAGE143
Gold wafer samples coated with each of the proteins BSA, γ-globulins and mixture of both 144
were washed with 1M Tris/HCl pH 8.4 buffer containing 0.1% SDS. After washing the 145
surface with the buffer repeatedly, the wafers were further shaken in the same buffer in a 146
sonication bath to enhance desorption of the coated proteins. The solution was then mixed 147
with laemmli buffer and analysed by SDS-PAGE.  148
149
Bacterial adhesion assay150
S. aureus SA113 (pC-tuf-ppmch) constitutively expresses red fluorescent protein mCherry 151
(Mauthe et al., 2012) was used in this work. In addition S. aureus SA113 WT (pC-tuf-gfp) 152
and the protein A deficient mutant S. aureus SA113 ∆ spa (pCX-pp-sfgfp), both expressing 153
the green fluorescent protein (gfp) were used as well. Bacteria were cultivated overnight at 37 154
°C and 120 rpm in basic medium (BM) composed of 1% peptone, 0.5% yeast extract, 0.5% 155
NaCl, 0.1% glucose and 0.1% K2HPO4. The overnight culture was inoculated into fresh 156
medium with an adjusted initial OD578 of 0.1 and grown to a density of 1.0. Bacterial cells 157
were then centrifuged and washed three times with sterile phosphate buffered saline (PBS). 158
Subsequently the bacteria were resuspended in PBS or bovine serum to OD578 of 1.0. Sterile 159
12-well cell culture plates (Greiner bio-one), onto which EG3OMe and PEG2k coated samples 160
were placed, were each filled with 4 ml bacteria suspensions. The plates were incubated at 161
37°C on a rotary shaker at 100 rpm. After 1 h incubation, the samples were washed three 162
times for five minutes in fresh PBS buffer and degassed Milli-Q water and finally dried with 163
an Argon stream. In the pre-incubation assay, the EG3OMe and PEG2k coated samples were 164
each pre-incubated for 1 h with PBS, BSA (20 mg/ml), γ-globulins (60 mg/ml) and bovine 165
serum (100%), in turn, before incubating with the bacteria suspension.  166
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167
Atomic Force Microscopy (AFM)168
Experiments were performed with a NanoWizard 3 AFM (JPK) in the tapping mode with a 169
line scan rate of 1 Hz and a resolution of 512×512 pixels. Scans were performed with a size of 170
1×1 µm2, 2×2 µm2, 5×5 µm2 and 10×10 µm2 to determine the average surface roughness. The 171
AFM images were treated with "Gwyddion" and the surface roughness and height distribution 172
were obtained. The mean-squared roughness (MSR) is given by the standard deviation of the 173
z-values for the surface height. It is quantified by the vertical deviations of a real surface from 174
its ideal form; if these deviations are large, the surface is rough, and if they are small the 175
surface is smooth.176
177
Polarization Modulation Infrared Reflection Absorption Spectroscopy (PMIRRAS)178
PMIRRAS measurements were performed on a Vertex70 Spectrometer (Bruker, Ettlingen, 179
Germany) equipped with a PMA50 extension (Bruker) featuring a photoelastic modulator, 180
purged with dry air. The spectra were recorded with a resolution of 4 cm-1 and 1024 scans per 181
measurement. The spectra were exported from the Bruker data acquisition program OPUS 182
and baseline corrected in Igor Pro (WaveMetrics, USA). The area, amplitude, width and 183
position of the modes in the fingerprint region were determined by fitting with a Gaussian 184
function (Roosen-Runge et al., 2010). Details of setup and data analysis have been described 185
elsewhere (Skoda et al., 2009). The detector was fixed at an angle of 75.8°. The sample holder 186
position was rotated to an angle of 82.9° to have the maximum interferogram signal (Skoda et 187
al., 2007). These settings were used for all measurements. Surface-bound proteins were 188
identified by the characteristic amide I (CO and N-H groups) absorption (the stretching 189
vibrations of the peptide carbonyl group), which lies in the range of 1600-1700 cm-1. 190
191
Fluorescence Microscopy192
Experiments were performed using a Leica DM5500 B microscope. Images were captured 193
with the Leica DFC360 FX high sensitivity monochrome digital camera. The fluorescence 194
coverage from each photo was calculated with the software "ImageJ", using a size of 1 µm2 as 195
an input parameter. 196
197
Results  198
199
Morphology and structure of EG3OMe and PEG2k coated surfaces200
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Both uncoated as well as EG3OMe and PEG2k coated gold (Au) surfaces were 201
analyzed by AFM with respect to morphology and mean-squared roughness (MSR) (Fig. 1). 202
The sputtered Au surfaces on silicon wafers had a grain-like morphology with a domain size 203
in the range of 50 -70 nm in diameter, MSR of 2.190.01 nm (Fig. 1A). These Au surfaces on 204
silicon wafers were coated with EG3OMe and PEG2k. The EG3OMe coated surfaces showed 205
a similar grain-like morphology with a similar domain size of ~60 nm in diameter (Fig. 1B).206
However, the surface became more flattened and more smooth as indicated by a decrease of 207
the MSR from 2.190.01 nm (Fig. 1A) to 1.580.02 nm. When the gold surface was coated 208
with PEG2k the surface became even smother as indicated by a drop of the MSR to 0.820.01 209
nm (Fig. 1C). An enlargement of the PEG2k coated surface is shown in Fig. 1D, which 210
indicates the formation of larger domains on PEG2k coated surface.211
212
EG3OMe and PEG2k coated surfaces did not adsorb lysozyme, fibrinogen and BSA at low 213
concentration214
The internal structures of EG3OMe and PEG2k coatings were characterized by 215
PMIRRAS (Fig. 2). The spectrum of EG3OMe coatings in air showed a single peak at 216
~1130cm-1 (C-O-C stretching mode) (Fig. 2A, black spectrum, red arrow), indicating that the 217
dominant conformation was the ordered helical conformation. The spectrum of PEG2k 218
coatings had a dominant peak at ~1130cm-1 (Fig. 2B, black spectrum, red arrow) with a 219
shoulder at ~1144cm-1 (Fig. 2B, black spectrum, blue arrow), suggesting a mixture of the 220
ordered helical and the less ordered all-trans conformations, but dominated by helical 221
conformation in the long polymer chain (Matsuura and Miyazawa, 1969; Miyazawa et al., 222
1962). 223
To test the protein adsorption properties of EG3OMe and PEG2k coated surfaces they 224
were incubated with selected blood proteins at a concentration of 1 mg/ml. The proteins vary 225
in molecular weight (Mw) and isoelectric point (pI). Lysozyme is a small protein (Mw=14.3 226
kD, pI=12) that is positively charged under physiological pH (Holmlin et al., 2001). 227
Fibrinogen is a large protein (Mw=340 kD) with negative charge (pI=6.0). BSA has an 228
intermediate protein size (Mw=68kD) and a pI of 4.6. PMIRRAS spectra of freshly prepared 229
EG3OMe and PEG2k coatings before and after incubating with protein solutions were shown 230
in Fig. 2. In all cases, no significant amide I band (1600-1700 cm-1) was visible after 231
incubating with proteins (Fig. 2, boxed square). The slight deviation from the baseline might 232
be due to the background subtraction. All other features of the absorption bands from the 233
thiols remained identical, indicating no conformation change of thiol molecules in the 234
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coatings after exposure to proteins. The amide I band is associated with the stretching 235
vibrations of the peptide carbonyl group, which has been widely used as an indicator to 236
monitor protein adsorption at interfaces (Barth and Zscherp, 2002). Our results showed that 237
both EG3OMe and PEG2k coatings are largely inert to protein binding, which is consistent 238
with a previous report (Zhu et al., 2001) .239
240
At high concentration (physiological) only γ-globulins and serum showed strong adsorption 241
to the coated surfaces but not albumin242
As shown above (Fig. 2), lysozyme, fibrinogen and BSA hardly adsorbed to EG3OMe and 243
PEG2k coated surfaces when applied at a concentration of 1 mg/ml. However, in blood serum 244
the concentration is much higher. In blood serum, the overall protein concentration is about 245
70 mg/ml. The two most abundant proteins are albumin ~60% (35 – 50 mg/ml) and γ-246
globulins ~18% (10 – 15 mg/ml) (Burtis and Ashwood, 1999). We thus extended our 247
experiments by increasing the protein concentrations (Fig. 3A) and also using a combination 248
of BSA and -globulin. 249
        PMIRRAS spectra indicated that the adsorption of BSA and lysozyme was very low for 250
both coatings, even at 100 mg/ml (Fig. 3B, purple and green lines). In contrast, the adsorption 251
of γ-globulins quickly reached a maximum at concentrations of 20 to 50 mg/ml, the 252
adsorption on PEG2k coatings was lower but continuously increased with protein 253
concentration (data not show). 254
When combinations of BSA and γ-globulins with a ratio of 3:1 were tested, protein 255
adsorption was significantly suppressed at all concentrations, indicating that BSA suppressed 256
the adsorption of γ-globulins (Fig. 3B, red line). The suppressive effect of BSA on γ-globulin 257
coating is also illustrated in SDS PAGE (Fig. 3C) and Fig. 3D.258
However, when whole bovine serum was tested the EG3OMe and PEG2k coating 259
showed different results (Fig. 3D). With EG3OMe coatings, the total protein adsorption of 260
serum was low and similar to that of BSA and γ-globulins mixture. With PEG2k coatings, the 261
protein adsorption of serum was significantly increased compared to BSA and γ-globulins 262
mixture (Fig. 3D, yellow bars), indicating that PEG2k coatings adsorbed some other proteins 263
in the serum apart from BSA and γ-globulins. 264
      Our results show that at physiological blood protein concentrations, the adsorption 265
behavior of BSA, γ-globulins and whole bovine serum varies with the coating. BSA showed 266
little adsorption on both coatings, whereas γ-globulins showed strong adsorption. BSA could 267
suppress γ-globulins adsorption when it was mixed with γ-globulins in a ratio of 3:1, which 268
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represents serum conditions. Whole serum had strong adsorption on PEG2k coatings, but not 269
on EG3OMe coatings, suggesting that some other serum proteins were adsorbed on the 270
PEG2k coatings.  271
272
Bacteria resuspended in buffer did not adhere EG3OMe and PEG2k coated surfaces 273
        The EG3OMe and PEG2k coated surfaces were also tested for bacterial adhesion. S. 274
aureus (pC-tuf-ppmch) that constitutively expressed red fluorescent protein mCherry was 275
suspended in PBS to an OD578 of 1.0 and incubated with coated and uncoated surfaces for 1 h. 276
The uncoated gold surface was heavily covered with cells, while the EG3OMe and PEG2k 277
coated surfaces were hardly covered with bacteria (Fig. 4A1, 2 and 3). This result was 278
confirmed by the quantitative analysis of the fluorescence coverage of the visual field (Fig. 6, 279
first block, 'PBS+PBS'). Our results show that EG3OMe and PEG2k coated surfaces were 280
largely inert to bacterial adhesion. We also tested other coating material with greater length,281
EG6OMe and PEG5K, and they showed similar results as EG3OMe and PEG2k (data not 282
shown).283
284
Pre-incubation of EG3OMe and PEG2k coated surfaces with -globulins or serum promoted 285
S. aureus adhesion286
As implant material usually comes in contact with plasma components it is important 287
to know what influence they have on bacterial adhesion. To address this question, we used 288
two experimental settings. In the first experiment, the coated surfaces were pre-incubated with 289
buffer (PBS control), BSA (20 mg/ml), γ-globulins (50 mg/ml) and bovine serum for 1 h. 290
Subsequently the surfaces were incubated with S. aureus (pC-tuf-ppmch) suspended in PBS 291
(OD578 of 1.0) for another hour. After removal of unbound bacteria by PBS-washings,292
bacterial adhesion was visualized with fluorescence microscopy. With this experiment, we 293
aimed to investigate whether there is a correlation between protein adsorption and bacterial 294
adhesion. When the coated surfaces were pre-incubated with BSA, which showed almost no 295
adsorption itself but significantly prevents adsorption of γ-globulins in mixed BSA-γ-296
globulins samples (Fig. 3B), there was no adherence of S. aureus observed compared to the 297
PBS control (Fig. 4A4). The results were comparable to untreated coatings as shown in Fig. 298
4A2 and 3. However, if the coated surfaces were pre-incubated with -globulins, which 299
readily adsorbs to the coated surfaces (Fig. 3), the adhesion of S. aureus was significantly 300
promoted (Fig. 4A5). The adherence of S. aureus to EG3OMe coating was higher than to 301
PEG2k coating, which correlates with the higher adsorption of -globulins to EG3OMe302
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coating (Fig. 3). In the quantitative fluorescence assay the amount of bacteria attached to 303
EG3OMe coatings was five-fold higher than that on PEG2k coatings (Fig. 6: -304
Globulin+PBS). If the coated surfaces were pre-incubated with bovine serum, S. aureus305
adhesion was also enhanced on both coatings (Fig. 4A6). 306
As shown in Fig. 6 (block 'serum+PBS'), twice as much bacteria were adhered to the 307
EG3OMe coatings than to PEG2k coatings, which correlated with the protein adsorption assay 308
(Fig. 3). There was a clear correlation between the amount of γ-globulins bound to the 309
surfaces and the amount of bacterial adhesion. As shown in Fig. 6 (blocks 'γ-Globulins+PBS' 310
and 'serum+PBS'), the bacteria attached after pre-incubating with 60 mg/ml γ-globulins were 311
six-fold higher than that after pre-incubating with serum where the γ-globulins were about 10 312
mg/ml. We assume that the adherence of S. aureus to serum-coated surfaces was essentially 313
due to the relatively high content of γ-globulins in the serum (approximately 20% of total 314
proteins are γ-globulins). We also tested human serum, which had the same effect as bovine 315
serum (data not show). 316
317
Pre-incubation of S. aureus with serum remarkably inhibited bacterial adhesion at EG3OMe 318
and PEG2k coated surfaces pretreated with γ-globulins or bovine serum319
In the above (Fig. 4A) experiment we resuspended S. aureus (pC-tuf-ppmch) in PBS, 320
which represents an artificial situation, because under in vivo conditions S. aureus comes in 321
close contact with serum. In order to better mimic the in vivo situation we resuspended S. 322
aureus in bovine and human serum and carried out the same adherence assay with EG3OMe 323
and PEG2k coatings pre-treated with BSA, γ-globulins or bovine serum as described above 324
(Fig. 4B). 325
Interestingly, resuspending S. aureus with bovine serum remarkably reduced S. aureus326
adhesion to EG3OMe and PEG2k coatings pre-treated with γ-globulins or bovine serum (Fig. 327
4B5 and 6). Apparently serum masks the S. aureus cell surface with serum components, most 328
likely γ-globulins, thus reducing its binding capacity to coatings pre-treated with γ-globulins 329
or serum. No binding of serum resuspended S. aureus was observed with coatings pre-treated 330
with BSA (Fig. 4B4), or with un-pretreated EG3OMe and PEG2k coatings (Fig. 4B2 and 3). 331
Even with the uncoated Au surface S. aureus (pC-tuf-ppmch) adherence was significantly 332
decreased (Fig. 4B1). The same effect was observed when S. aureus (pC-tuf-ppmch) was 333
resuspended with human serum (not shown). The results are summarized in the quantitative 334
analysis diagram (Fig. 6). 335
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       The pretreatment of EG3OMe and PEG2k coatings with γ-globulins or bovine serum 336
caused massive adhesion of S. aureus. We assume that might be due to the fact that S. aureus337
harbors high immunoglobulin-binding activity by its cell-wall bound protein A (Spa) (Löfdahl 338
et al., 1983; Uhlen et al., 1984). The 'second immunoglobulin-binding protein' (Sbi) is 339
secreted (Zhang et al., 1998) and should not play a major role in adherence. To prove the 340
hypothesis, S. aureus SA113∆spa (pCX-pp-sfgfp), which is a Protein A deficient mutant 341
strain, was used for the tests on uncoated Au or PEG5K coated surfaces. When the bacteria 342
were resuspended in PBS, the uncoated Au surface was heavily covered by both strains (Fig. 343
5A1 and B1). If WT and ∆spa mutant were resuspended in buffer there was no adherence to 344
PEG5K coated surface (Fig. 5A2 and B2). Was the  PEG5K coated surface pretreated with γ-345
globulins the WT showed good adherence, while the ∆spa mutant did not adhere (Fig. 5A3 346
and B3). When the bacteria were resuspended in bovine serum, the wafers were adhered by347
neither WT S. aureus nor ∆spa mutant (Fig. 5A4 and B4).  348
We showed the different adsorption behavior of albumin, γ-globulins and serum on 349
EG3OMe and PEG2k coatings and the effect on bacterial adhesion. Although, albumin 350
showed little adsorption to the surfaces, it still caused a decrease of S. aureus adhesion. γ-351
globulins strongly adsorbed to the surfaces and promoted S. aureus adhesion. But most 352
important was the observation that pre-incubation of S. aureus with γ-globulins or serum 353
significantly decreased the adherence to coatings that came in contact with γ-globulins or 354
serum - that is the natural situation of implanted material. 355
356
Pretreatment of Pseudomonas aeruginosa with serum significantly decreased its adherence to 357
the coatings358
We also carried out similar adherence studies with GFP expressing Pseudomonas 359
aeruginosa and obtained similar results as with S. aureus. P. aeruginosa showed massive 360
adherence to uncoated gold (Au) surfaces (Fig. 7A and B); if the cells were however 361
resuspended with bovine serum adherence to uncoated gold (Au) surfaces was decreased (Fig. 362
7B). Like S. aureus, P. aeruginosa hardly adhered to EG3OMe and PEG2k coated surfaces 363
even when resuspended in buffer (Fig. 7B).364
365
366
Discussion367
      The aim of this study was to systematically analyze the adherence behavior of gold (Au) 368
as well as EG3OMe or PEG2k coated Au surfaces to plasma proteins and pathogenic bacteria 369
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such as S. aureus, which plays a crucial role in implant-associated infections. The coating 370
altered the physical appearance of the surface. The sputtered Au surfaces on silicon wafers 371
had a rough and grain-like morphology, which became smoother and flattened by EG3OMe 372
and even more smooth by PEG2k coating (Fig. 1). 373
The EG3OMe and PEG2k coated surfaces were inert to adsorption of the blood 374
proteins lysozyme, fibrinogen and albumin (BSA) if applied at low concentration (1 mg/ml) 375
(Fig. 2) and they were inert to adherence of S. aureus (Fig. 4). BSA did not adsorb to the 376
coated surfaces even when applied at very high concentrations (100 mg/ml), which is in line 377
with the literature (Holmlin et al., 2001; Lokanathan et al., 2011; Prime and Whitesides, 378
1993). However, -globulin adsorbed to the EG3OMe and PEG2k coatings if applied at 379
concentrations higher than 10 mg/ml (Fig. 3); its adsorption could be, however, significantly 380
suppressed if it was mixed with BSA in a ratio of 1:3 as it also occurs in serum. As BSA itself 381
did not adsorb to the EG3OMe and PEG2k coatings we assume that BSA is neutralizing -382
globulin's binding domains already in solution. Indeed, it has been shown recently that serum 383
albumin has a moderate attraction to IgGs, which may forestall undesirable protein 384
condensation in antibody solutions (Wang et al., 2011). We also found that PEG2k coatings 385
adsorbed four times less γ-globulins than the EG3O e coatings. One reason could be that the 386
long polymer chains of PEG2k cover the coating Au substrate more efficiently then EG3OMe, 387
with the effect that steric repulsion prevents γ-globulin adsorption more efficiently (Jeon and 388
Andrade, 1991). On the other hand, adherence of whole serum was five times higher with the 389
PEG2k coated surface than with the EG3OMe coated one (Fig. 3D). A possible reason for this 390
observation might be that PEG2k has a much longer thread-like structure than EG3OMe and 391
revealed a lower surface coverage than the EG3OMe coating. We assume that small proteins 392
(other than -globulins) can more easily penetrate the PEG2k polymer brush thus enhancing393
the adsorption on PEG2k coatings (Benesch et al., 2001). 394
The question is why BSA and lysozyme do not bind to the coatings, even at very high 395
concentrations, while -globulins do. Serum albumin is the most abundant plasma protein in 396
mammals with an extraordinary ligand binding capacity; these proteins are relatively large 397
(66 kDa) and negatively charged (Majorek et al., 2012). Lysozymes also have a positive net 398
charge that is thought to play an important role in guiding lysozyme to the negatively charged 399
surface of bacteria. The majority of -globulins are immunoglobulins (150 kDa), which are 400
also positively charged. Apparently, the charge of the proteins does not play a crucial role in 401
binding to the coatings, as the positive charged lysozyme and -globulins show opposing 402
binding effect. Therefore, we assume that specific binding domains in -globulins interact 403
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with the PEG2k and EG3OMe coatings. It would be interesting to know whether it is the Fc or 404
the Fab part of IgG that mediates binding to PEG2k and EG3OMe. 405
       The pretreatment of EG3OMe and PEG2k coatings with γ-globulins or bovine serum 406
caused massive adhesion of S. aureus (Fig. 4A). This is not so surprising as it is well-known 407
that S. aureus is distinguished by its high immunoglobulin-binding activity via its cell-wall 408
bound protein A (Spa) (Löfdahl et al., 1983; Uhlen et al., 1984). The 'second 409
immunoglobulin-binding protein' (Sbi) is secreted and it contributes to complement evasion410
(Burman et al., 2008; Zhang et al., 1998); but it should not play major role in adherence of 411
cells to the coatings(Burman et al., 2008; Zhang et al., 1998). In this experiment S. aureus412
cells were resuspended in buffer (PBS). However, if we resuspended S. aureus cells with 413
bovine or human serum the adherence to the γ-globulins or serum treated coatings was 414
significantly decreased (Fig. 4B). Besides, S. aureus spa was not detectable on any PEG 415
surfaces, even on the γ-globulins pre-incubated surfaces (Fig. 5). This decreased adherence is 416
due to the saturation of Spa by IgGs present in the serum. Based on this observation implant-417
associated infections might be minimized by allowing bacterial pathogens to become 418
saturated with the patient's serum.419
The function of serum in preventing bacterial adhesion is not restricted to S. aureus, 420
we also see this effect with P. aeruginosa. One possible explanation could be that the 421
abundant albumin in the serum neutralizes γ-globulins via non-specific attraction as 422
mentioned above (Wang et al., 2011), thereby decreasing the bacterial adhesion. With respect 423
to Gram-negative bacteria, like P. aeruginosa, one must also consider the complement factors 424
present in serum that might play a role in decreasing bacterial adhesion. Since the 425
composition of serum is complex, many factors might play a role. For instance, it has been 426
reported that apo-transferrin prevented bacterial adhesion to the Tecoflex polyurethane 427
surfaces (Elofsson et al., 1997). Kuroda et al. observed that serum globulins could reduce the 428
adhesion of Prevotella nigrescens to hydroxyapatite (Kuroda et al., 2003). Future 429
investigations should focus on identifying more inhibitory components of serum. 430
On the other hand, pre-incubation of the surfaces with albumin did not promote S. 431
aureus adhesion, even when the cells were resuspended with serum. It has been known for a 432
while that surface coatings with albumin have an inhibitory effect on bacterial adhesion. It has 433
been reported that albumin adsorbs to the interface and creates a thin film that prevents 434
bacterial adhesion (Ardehali et al., 2003; Katsikogianni and Missirlis, 2004; Ribeiro et al., 435
2012). However, the role of albumin is not fully understood. In our experiments, the 436
'protective' role of albumin on bacterial adhesion can be simply explained by the fact that it is 437
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not adsorbed on the EG3OMe and PEG2k surfaces and has therefore no further influence on 438
bacterial adhesion. It would be interesting to test in future experiments whether albumin in the 439
solution will inhibit bacterial adhesion onto a surface, especially when the surfaces are pre-440
incubated with γ-globulins. 441
In conclusion, our study contributes to a better understanding about the functions of 442
the major serum components on protein adsorption and S. aureus adhesion on EG3OMe and 443
PEG2k coated surfaces. In particular, we found that serum can significantly inhibit the 444
bacteria adhesion on different surfaces, which might have some therapeutic implications in 445
minimizing implant-associated infections. 446
447
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453
Figure legends 454
455
Figure 1. AFM height images (1µm x 1µm) of gold surface alone (A), gold surface coated 456
with EG3OMe (B) or PEG2k (C, D). The images show the surface morphology. The mean 457
squared surface roughness was deduced from the AFM images using software "Gwyddion". 458
By coating the gold surface with EG3OMe and PEG2k the mean-squared roughness (MSR) 459
decreased more and more, becoming smoother. The yellow to brown color scales beside the 460
images indicate the vertical scale. 461
462
Figure 2. Structure and determination of protein adherence to EG3OMe (A) and PEG2k (B) 463
coatings by PMIRRAS spectral analysis. The peaks seen in the range between 1500 – 900 nm 464
were specific for the coated material EG3OMe and PEG2k (black spectrum); arrows indicate 465
the main peaks. After incubation with selected blood proteins (1 mg/ml) spectral analysis with 466
potentially adhered proteins was carried out again: lysozyme (green-), fibrinogen (red-) and 467
BSA (blue spectrum). The boxed square indicates the amide I region 1600-1700 cm-1, which 468
is characteristic for protein absorption; there is little adherence of these proteins to EG3OMe 469
or PEG2k coated gold (Au) surface.470
471
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Figure 3. γ-globulin binding to EG3OMe and PEG2k coated surfaces. (A) PMIRRAS spectra 472
of EG3OMe coated surfaces incubated with different concentrations of γ-globulins. (B) 473
Serum protein adherence was determined by amide I absorbance peak intensity from 474
PMIRRAS spectra: BSA (purple line), γ-globulins (blue line), mixtures of BSA and γ-475
globulins with a concentration ratio of 3:1 (red line) and lysozyme (Lyz, green line). The 476
concentrations used were 1, 10, 20, 50 and 100 mg/ml. (C) Analysis of serum proteins eluted 477
from EG3OMe coated surface by SDS-PAGE and Coomassie protein staining. (D) Graphical 478
representation of the adherence capacity of BSA (bovine serum albumin), γ-globulins, γ-479
globulins together with BSA and bovine serum on EG3OMe and PEG2k surfaces.480
481
Figure 4. Effect of S. aureus resuspended in PBS buffer (A) or serum (B) on adherence to 482
EG3OMe and PEG2k coated surfaces. Fluorescence microscopy images of S. aureus (pC-tuf-483
ppmch) adhered on uncoated Au surface (1), EG3OMe coated surface (2), PEG2k coated 484
surface (3) and EG3OMe coated surfaces pre-incubated with 20 mg/ml BSA (4), 50 mg/ml γ-485
globulins (5) or 100% bovine serum (6).486
487
Figure 5. Comparison of S. aureus WT (A) and protein A mutant (B) on adherence. 488
Fluorescence microscope images of S. aureus adhesion on uncoated gold (Au) surfaces (1),489
PEG5k coated (2) and PEG5k coated surfaces pre-incubated with 50 mg/ml γ-globulins (3 490
and 4). Wafers were incubated with S. aureus SA113 WT (pC-tuf-gfp) or SA113∆spa (pCX-491
pp-sfgfp); cells were either resuspended in PBS (buffer) or bovine serum (BS).   492
493
Figure 6. Quantitative analysis of S. aureus (pC-tuf-ppmch) adhesion under different 494
conditions. The coverage of red fluorescent S. aureus was calculated by software 'ImageJ', 495
using a size of 1 µm2 as an input parameter. The analyzed square seen in Fig. 3 was approx. 496
200 m x 120 m). The name for each block indicates the experimental conditions as 'surface 497
pre-incubation vs. bacteria suspension'; for example: 'BSA+serum' means that the surfaces 498
were pre-incubated in BSA and the bacteria were resuspended in serum. Blue bars, uncoated 499
Au surfaces; red bars, EG3OMe coated surfaces; green bars, PEG2k coated surfaces. 500
501
Figure 7. Adherence comparison between S. aureus and P. aeruginosa. (A) Fluorescence 502
images on uncoated gold (Au) surfaces after incubation with S. aureus or P. aeruginosa in 503
PBS buffer. (B) Comparison of the cell counts on uncoated gold (Au) surfaces, EG3OMe 504
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coated and PEG2k coated surfaces for S. aureus and P. aeruginosa resuspended in PBS buffer 505
or bovine serum.506
507
508
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